[go: up one dir, main page]

CN111233908A - Benzoxaborol-1-ol compound and preparation method and application thereof - Google Patents

Benzoxaborol-1-ol compound and preparation method and application thereof Download PDF

Info

Publication number
CN111233908A
CN111233908A CN202010090057.0A CN202010090057A CN111233908A CN 111233908 A CN111233908 A CN 111233908A CN 202010090057 A CN202010090057 A CN 202010090057A CN 111233908 A CN111233908 A CN 111233908A
Authority
CN
China
Prior art keywords
iii
benzoxaborol
compound
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010090057.0A
Other languages
Chinese (zh)
Inventor
张明智
刘畅
施展
章维华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Agricultural University
Original Assignee
Nanjing Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Agricultural University filed Critical Nanjing Agricultural University
Publication of CN111233908A publication Critical patent/CN111233908A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/08Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing boron

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)

Abstract

本发明属于杀菌剂领域,具体涉及苯并氧杂硼‑1‑醇类化合物及其制备方法和用途。苯并氧杂硼‑1‑醇类化合物具有很好的杀菌活性,可以有效地控制番茄早疫病、小麦赤霉病、水稻纹枯病、草莓灰霉病、苹果斑点病、黄瓜炭疽病等农作物病害,在低浓度下即可获得优异的抑菌效果,且表现出良好的选择性。该类化合物作为亮氨酰‑tRNA合成酶抑制剂,利用病菌和真核生物的氨酰‑tRNA合成酶的进化差异,在杀灭病菌的同时,对非靶标生物具有很高安全性,在农业上可用作杀菌剂。The invention belongs to the field of bactericides, and in particular relates to a benzoxaborol-1-alcohol compound and a preparation method and application thereof. Benzoxaborol-1-alcohol compounds have good bactericidal activity and can effectively control crops such as tomato early blight, wheat scab, rice sheath blight, strawberry gray mold, apple spot, cucumber anthracnose, etc. Disease, excellent bacteriostatic effect can be obtained at low concentration, and it shows good selectivity. As leucyl-tRNA synthetase inhibitors, these compounds take advantage of the evolutionary differences between the aminoacyl-tRNA synthetase of pathogens and eukaryotes to kill pathogens and at the same time have high safety to non-target organisms, and are used in agriculture. Can be used as a fungicide.

Description

苯并氧杂硼-1-醇类化合物及其制备方法和应用Benzoxaborol-1-ol compounds, preparation method and application thereof

技术领域technical field

本发明涉及农用杀菌剂领域,具体涉及苯并氧杂硼-1-醇类化合物及其制备方法和应用。The invention relates to the field of agricultural fungicides, in particular to benzoxaborol-1-ol compounds and a preparation method and application thereof.

背景技术Background technique

氨酰-tRNA合成酶是人类疾病的新型作用靶标,广泛存在于原核及真核生物中,是蛋白质合成中的一类重要的蛋白。氨酰-tRNA合成酶作用机制分为两步:首先,氨基酸和ATP在氨酰-tRNA合成酶催化下反应,获得被活化、可水解的氨酰腺苷酸中间体。然后,氨酰-tRNA合成酶催化氨基酸分子转移到其同源tRNA,获得的氨酰-tRNA作为底物参与在核糖体中进行的多肽合成。由于氨酰-tRNA合成酶催化特定氨基酸连接到对应的tRNA上,该反应是蛋白合成的第一步,决定了蛋白质的正确翻译,所以该酶对细胞的存活起着极其重要的作用。而且,利用原核生物和真核生物细胞中的氨酰-tRNA合成酶间较大的进化差异,可以开发选择性高、副作用小的抗菌药物。Aminoacyl-tRNA synthetase is a novel target of human diseases, widely exists in prokaryotic and eukaryotic organisms, and is an important protein in protein synthesis. The mechanism of action of aminoacyl-tRNA synthetase is divided into two steps: First, aminoacyl-tRNA synthetase reacts with ATP under the catalysis of aminoacyl-tRNA synthetase to obtain an activated and hydrolyzable aminoacyladenylate intermediate. Then, aminoacyl-tRNA synthetase catalyzes the transfer of amino acid molecules to its cognate tRNA, and the obtained aminoacyl-tRNA serves as a substrate to participate in polypeptide synthesis in the ribosome. Since aminoacyl-tRNA synthetase catalyzes the linking of specific amino acids to the corresponding tRNA, this reaction is the first step in protein synthesis and determines the correct translation of the protein, so the enzyme plays an extremely important role in the survival of cells. Moreover, taking advantage of the large evolutionary differences between aminoacyl-tRNA synthetases in prokaryotic and eukaryotic cells, antibacterial drugs with high selectivity and few side effects can be developed.

苯并硼环类化合物是亮氨酰-tRNA合成酶抑制剂,该结构中的硼原子可以在亮氨酸-tRNA合成酶的编辑域与亮氨酸的tRNA末端的腺苷形成螺环加合物,作为非竞争性抑制剂抑制亮氨酰-tRNA合成酶的活性。开发新型的氨酰-tRNA合成酶抑制剂对于研发优良作用活性、低耐药性及高选择性的杀菌剂十分重要,目前,苯并硼环类药物研究集中于抗真菌、抗肿瘤等领域,已上市的抗真菌感染药Kerydin的活性成分就是苯并硼环类化合物tavaborole。化学合成的氨酰-tRNA合成酶抑制剂主要有苄基苯基醚类、乙醇胺类、喹啉酮类、联苯取代的吡唑类及苯并硼环类。Benzoboron compounds are leucyl-tRNA synthetase inhibitors. The boron atom in this structure can form a spiro adduct with adenosine at the tRNA end of leucine in the editing domain of leucine-tRNA synthetase. It acts as a non-competitive inhibitor to inhibit the activity of leucyl-tRNA synthetase. The development of novel aminoacyl-tRNA synthetase inhibitors is very important for the development of fungicides with excellent activity, low drug resistance and high selectivity. The active ingredient of the marketed antifungal infection drug Kerydin is tavaborole, a benzoborane ring compound. Chemically synthesized aminoacyl-tRNA synthetase inhibitors mainly include benzyl phenyl ethers, ethanolamines, quinolinones, biphenyl-substituted pyrazoles and benzoboranes.

但是,尚未见苯并硼环类化合物关于农业病害防治领域的应用。However, the application of benzoborane compounds in the field of agricultural disease control has not yet been seen.

发明内容SUMMARY OF THE INVENTION

发明目的:本发明的目的是提供苯并氧杂硼-1-醇类化合物及该类化合物的制备方法和在杀菌方面的应用。Purpose of the invention: The purpose of the present invention is to provide benzoxaborol-1-ol compounds and their preparation methods and applications in sterilization.

技术方案:为了实现上述目的,本发明采用的技术方案如下:Technical scheme: in order to achieve the above object, the technical scheme adopted in the present invention is as follows:

一方面,本发明提供了苯并氧杂硼类-1-醇类化合物,该类化合物具有如下结构式:In one aspect, the present invention provides benzoxaborol-1-alcohol compounds, which have the following structural formula:

Figure BDA0002383090810000021
Figure BDA0002383090810000021

其中,R与4、5、6或7位C相连,R为-R1或-L-R3,R’为-CH2-或-Y-CH2-;Wherein, R is connected to C at 4, 5, 6 or 7, R is -R 1 or -LR 3 , and R' is -CH 2 - or -Y-CH 2 -;

其中,R1选自氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基、C2-C8醛基卤代炔基、碳芳基、杂环基、氰基、硝基以及其他基团中的一种;wherein, R 1 is selected from hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkyne group, C 2 -C 8 haloalkynyl, C 1 -C 8 hydroxyalkyl, C 1 -C 8 hydroxy haloalkyl, C 2 -C 8 hydroxy alkenyl, C 2 -C 8 hydroxy haloalkenyl, C 2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 - C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 -mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl , C 1 -C 8 alkylthio, C 1 -C 8 Haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldehyde Alkyl alkyl, C 1 -C 8 aldohaloalkyl, C 2 -C 8 aldoalkenyl, C 2 -C 8 aldohaloalkenyl, C 2 -C 8 aldoalkynyl, C 2 -C 8. One of aldehyde haloalkynyl, carboaryl, heterocyclic, cyano, nitro and other groups;

所述其他基团为被1或多个独立选自以下基团取代的氨基、羰基、硫代羰基、磺酰基、羰基氨基、磺酰基氨基、硫代羰基氨基、氨基羰基、氨基磺酰基、氨基硫代羰基:氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、氰基或硝基;The other groups are amino, carbonyl, thiocarbonyl, sulfonyl, carbonylamino, sulfonylamino, thiocarbonylamino, aminocarbonyl, aminosulfonyl, amino substituted with one or more groups independently selected from Thiocarbonyl: hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C2 - C8haloalkynyl , C1 - C8hydroxyalkyl , C1 - C8hydroxyhaloalkyl , C2- C8hydroxyalkenyl , C2 - C8hydroxyhaloalkenyl , C2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkene Oxy group, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 alkylthio, C 1 -C 8 haloalkylthio group, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, cyano or nitro;

其中,L指桥链结构,选自O、S、CHR4、NR5、COO、硫代羰基、磺酰基、羰基氨基、磺酰基氨基、硫代羰基氨基、氨基羰基、氨基磺酰基或氨基硫代羰基,R4、R5独立选自氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基或C2-C8醛基卤代炔基;Wherein, L refers to a bridge structure, selected from O, S, CHR 4 , NR 5 , COO, thiocarbonyl, sulfonyl, carbonylamino, sulfonylamino, thiocarbonylamino, aminocarbonyl, aminosulfonyl or aminothio substituted carbonyl, R 4 , R 5 are independently selected from hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 - C8alkynyl , C2 - C8haloalkynyl , C1 - C8hydroxyalkyl , C1 - C8hydroxyhaloalkyl , C2 - C8hydroxyalkenyl , C2- C8hydroxyl Haloalkenyl, C 2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyl group, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl , C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercapto alkynyl , C 1 -C 8 alkylthio, C 1 -C 8 haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldol alkyl, C 1 -C 8 aldol haloalkyl, C 2 -C 8 aldol alkenyl, C 2 -C 8 aldol haloalkenyl, C 2 -C 8 aldol alkynyl or C 2 -C 8 aldehyde haloalkynyl;

其中,R3为碳芳基或杂环基;进一步地,R3选自氧硫杂环、吗啉、吡啶、嘧啶、哒嗪、喹啉、吡唑、噻唑、异噻唑、噻二唑、噻吩、呋喃、噁唑、异噁唑、噁二唑,以及这些杂环含氟、含氯的衍生物;wherein, R 3 is a carboaryl group or a heterocyclic group; further, R 3 is selected from oxa-thiacycle, morpholine, pyridine, pyrimidine, pyridazine, quinoline, pyrazole, thiazole, isothiazole, thiadiazole, Thiophene, furan, oxazole, isoxazole, oxadiazole, and fluorine- and chlorine-containing derivatives of these heterocycles;

其中,Y与苯环相连,选自O、S、CH2、未取代或被1个独立选自以下基团取代的氨基:卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基、C2-C8醛基卤代炔基、碳芳基或杂环基。Wherein, Y is connected to the benzene ring, selected from O, S, CH 2 , unsubstituted or amino substituted by 1 group independently selected from the following groups: halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl , C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, C 1 -C 8 hydroxyalkyl, C 1 -C 8 -hydroxyhaloalkyl, C2 - C8hydroxyalkenyl , C2 - C8hydroxyhaloalkenyl , C2 - C8hydroxyalkynyl , C2- C8hydroxyhaloalkynyl , C1 - C8 Alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkyne oxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 -C 8 alkylthio, C 1 -C 8 haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldol alkyl, C 1 -C 8 aldol haloalkyl, C 2 -C 8 aldol alkenyl, C 2 -C8 aldohaloalkenyl , C2 - C8 aldoalkynyl , C2 - C8 aldohaloalkynyl , carboaryl or heterocyclyl.

第二方面,本发明提供了具有式(I)所示的结构的苯并氧杂硼-1-醇类化合物:In a second aspect, the present invention provides a benzoxaborol-1-ol compound having the structure shown in formula (I):

Figure BDA0002383090810000031
Figure BDA0002383090810000031

第三方面,本发明提供了具有式(II)所示的结构的苯并氧杂硼-1-醇类化合物:In a third aspect, the present invention provides a benzoxaborol-1-ol compound having the structure shown in formula (II):

Figure BDA0002383090810000032
Figure BDA0002383090810000032

第四方面,本发明提供了具有式(Ⅲ)所示的结构的苯并氧杂硼-1-醇类化合物,该类化合物:In a fourth aspect, the present invention provides a benzoxaborol-1-ol compound having a structure represented by formula (III), the compound:

Figure BDA0002383090810000041
Figure BDA0002383090810000041

第五方面,本发明还提供了当R为-R1,R’为-CH2-时,所述苯并氧杂硼类-1-醇类化合物的制备方法如下:溴代苯甲醛或溴代苯甲酸类化合物或氰基取代的溴代甲苯类化合物与氯甲基甲醚反应,转换为羟基被甲氧基甲基保护的溴代苯甲醇类化合物,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,最后在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物;In the fifth aspect, the present invention also provides that when R is -R 1 and R' is -CH 2 -, the preparation method of the benzoxaborol-1-alcohol compounds is as follows: bromobenzaldehyde or bromine Substituted benzoic acid compounds or cyano-substituted bromotoluene compounds react with chloromethyl methyl ether to convert into bromobenzyl alcohol compounds whose hydroxyl groups are protected by methoxymethyl, and then react with triisopropyl borate in normal The low temperature reaction in tetrahydrofuran solvent of butyllithium causes the boron atom to be connected to the benzene ring, and finally deprotected in hydrochloric acid to spontaneously form a ring to obtain the corresponding benzoxaborol-1-ol compounds;

或当R为-R1,R’为-Y-CH2-时,所述苯并氧杂硼类-1-醇类化合物的制备方法如下:由溴代苯甲醛类化合物发生维蒂希反应经水解后得到溴代苯乙醛类化合物,再与氯甲基甲醚反应,得到羟基被甲氧基甲基保护的溴代苯乙醇类化合物,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的六元苯并氧杂硼-1-醇类化合物。Or when R is -R 1 and R' is -Y-CH 2 -, the preparation method of the benzoxaborol-1-alcohol compounds is as follows: Wittig reaction occurs from bromobenzaldehyde compounds After hydrolysis, bromophenylacetaldehyde compounds are obtained, which are then reacted with chloromethyl methyl ether to obtain bromophenethyl alcohol compounds whose hydroxyl groups are protected by methoxymethyl groups, and finally reacted with triisopropyl borate in n-butyl group. The low temperature reaction of lithium in tetrahydrofuran solvent causes the boron atom to be attached to the benzene ring, deprotected in hydrochloric acid, and spontaneously forms a ring to obtain the corresponding six-membered benzoxaborol-1-ol compounds.

或当R为L-R3,R’为-CH2-,L为S、O时,由(硫)酚类化合物Ⅲ-9和2-溴-4-氟苯甲醛反应得到(硫)醚类化合物,再经硼氢化钠还原得Ⅲ-12,然后Ⅲ-12与氯甲基甲醚反应得Ⅲ-13,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物Ⅲ-14。Ⅲ-14也可由Ⅲ-11在钯的催化下与双联频哪醇基二硼反应得Ⅲ-15水解还原得到,合成路线如下:Or when R is LR 3 , R' is -CH 2 -, and L is S, O, the (thio) ether compound is obtained by the reaction of (thio)phenol compound III-9 and 2-bromo-4-fluorobenzaldehyde , and then reduced by sodium borohydride to obtain III-12, then III-12 reacts with chloromethyl methyl ether to obtain III-13, and finally reacts with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to make boron atom Connected to the benzene ring, deprotected in hydrochloric acid, and spontaneously formed a ring to obtain the corresponding benzoxaborol-1-ol compound III-14. III-14 can also be obtained by the hydrolysis and reduction of III-15 by reacting III-11 with double pinacol-based diboron under the catalysis of palladium. The synthetic route is as follows:

Figure BDA0002383090810000051
Figure BDA0002383090810000051

或当R为L-R3,R’为-CH2-,L为硫代羰基、磺酰基时,化合物Ⅲ-14经高碘酸钠氧化分别得到相应的苯并氧杂硼-1-醇类化合物Ⅲ-16和Ⅲ-17,合成路线如下:Or when R is LR 3 , R' is -CH 2 -, and L is thiocarbonyl, sulfonyl, compound III-14 is oxidized by sodium periodate to obtain the corresponding benzoxaborol-1-ols, respectively Ⅲ-16 and Ⅲ-17, the synthetic route is as follows:

Figure BDA0002383090810000052
Figure BDA0002383090810000052

或当R为L-R3,R’为-CH2-,L为羰基时,取代苯或杂环类化合物Ⅲ-18和Ⅲ-19发生傅克反应得化合物Ⅲ-20,然后经溴代丁二酰亚胺溴代、与醋酸钠在碱性条件下水解得化合物Ⅲ-21,接着氧化得到化合物Ⅲ-22,然后与乙二醇反应得化合物Ⅲ-23,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的化合物Ⅲ-25,最后用沙瑞特试剂反应得苯并氧杂硼-1-醇类化合物Ⅲ-26,合成路线如下:Or when R is LR 3 , R' is -CH 2 -, and L is carbonyl, substituted benzene or heterocyclic compounds III-18 and III-19 undergo Friedel-Crafts reaction to obtain compound III-20, which is then subjected to bromobutanediol. The imide is brominated, hydrolyzed with sodium acetate under alkaline conditions to obtain compound III-21, and then oxidized to obtain compound III-22, which is then reacted with ethylene glycol to obtain compound III-23, which is then reacted with triisopropyl borate in normal The low temperature reaction of butyllithium in tetrahydrofuran solvent makes the boron atom connect to the benzene ring, deprotection in hydrochloric acid, and spontaneously form a ring to obtain the corresponding compound III-25, which is finally reacted with Sarreth reagent to obtain benzoxaborol-1 -Alcohol compound III-26, the synthetic route is as follows:

Figure BDA0002383090810000061
Figure BDA0002383090810000061

或当R为L-R3,R’为-CH2-,L为羰基氨基、硫代羰基氨基、磺酰基氨基时,化合物Ⅲ-27与不同的酰氯、硫代酰氯、磺酰氯偶联形成由L连接的苯并氧杂硼-1-醇类化合物Ⅲ-28、Ⅲ-29、Ⅲ-30,合成路线如下:Or when R is LR 3 , R' is -CH 2 -, and L is carbonylamino, thiocarbonylamino, sulfonylamino, compound III-27 is coupled with different acid chlorides, thioacyl chlorides, and sulfonyl chlorides to form L Connected benzoxaborol-1-alcohol compounds III-28, III-29, III-30, the synthetic route is as follows:

Figure BDA0002383090810000062
Figure BDA0002383090810000062

或当R为L-R3,R’为-CH2-,L为NH时,由碘代化合物Ⅲ-31和化合物Ⅲ-32,在叔丁氧羰基保护下形成醇类化合物Ⅲ-35,然后再与3,4-二氢吡喃在吡啶存在下,形成四氢吡喃保护的醇羟基,最后在酸性条件下脱保护并形成苯并氧杂硼-1-醇类化合物Ⅲ-39,合成路线如下:Or when R is LR 3 , R' is -CH 2 -, and L is NH, an alcohol compound III-35 is formed from the iodo compound III-31 and compound III-32 under the protection of tert-butoxycarbonyl group, and then With 3,4-dihydropyran in the presence of pyridine, the alcohol hydroxyl group protected by tetrahydropyran is formed, and finally deprotected under acidic conditions to form benzoxaborol-1-ol compounds III-39, synthetic route as follows:

Figure BDA0002383090810000071
Figure BDA0002383090810000071

或当R为L-R3,R’为-CH2-,L为CH2时,硼酸类化合物Ⅲ-40和2-甲氧基-4-溴苯甲醛发生Suzuki偶联反应得到Ⅲ-42,再经三氟磺酸酐在三氯化铈和碘化钠作用下转化成三氟甲基磺酸盐Ⅲ-44,经硼烷化后,最终在酸性条件下水解得相应的苯并氧杂硼-1-醇类化合物Ⅲ-46,合成路线见下:Or when R is LR 3 , R' is -CH 2 -, and L is CH 2 , boronic acid compound III-40 and 2-methoxy-4-bromobenzaldehyde undergo Suzuki coupling reaction to obtain III-42, and then The trifluorosulfonic anhydride was converted into trifluoromethanesulfonate III-44 under the action of cerium trichloride and sodium iodide, and after boranization, the corresponding benzoxaboron- 1-alcohol compound III-46, the synthetic route is as follows:

Figure BDA0002383090810000072
Figure BDA0002383090810000072

第六方面,本发明还提供了苯并氧杂硼类-1-醇类化合物在防治农作物病害领域中的应用。In a sixth aspect, the present invention also provides the application of benzoxaborol-1-alcohol compounds in the field of preventing and treating crop diseases.

其中,所述农作物病害为早疫病菌、赤霉病菌、纹枯病菌、灰霉病菌、腐霉病菌、斑点病菌、炭疽病菌、晚疫病菌和霜霉病菌中的一种或几种。Wherein, the crop disease is one or more of early blight, head blight, sheath blight, botrytis cinerea, pythium, speckle, anthracnose, late blight and downy mildew.

上式给出的式(I)~(Ⅲ)化合物的定义中,汇集所用术语一般定义如下:In the definitions of the compounds of the formulae (I) to (III) given by the above formulas, the terms used in the collection are generally defined as follows:

所谓的卤素是指氟、氯、溴或碘。By halogen is meant fluorine, chlorine, bromine or iodine.

所谓的烷基是指直链、支链或环状链形式,例如甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、正戊基、异戊基、正己基、环丙基、环丁基等基团。卤代烷基是指烷基被一个或多个卤原子取代的基团,例如,氯甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基等。所谓的烯基是指直链、支链或环状链烯类,例如乙烯基、1-丙烯基、2-丙烯基和不同的丁烯基、戊烯基和己烯基异构体。烯基还包括多烯类,如1,2-丙二烯基、2,4-己二烯基等。所谓的炔基是指直链、支链或环状链炔类,例如乙炔基、丙炔基、炔丙基等。By alkyl we mean straight, branched or cyclic chain forms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl group, isopentyl, n-hexyl, cyclopropyl, cyclobutyl and other groups. Haloalkyl refers to groups in which the alkyl group is substituted with one or more halogen atoms, eg, chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, and the like. By alkenyl is meant straight-chain, branched or cyclic alkenes such as vinyl, 1-propenyl, 2-propenyl and the different butenyl, pentenyl and hexenyl isomers. Alkenyl also includes polyenes such as 1,2-propadienyl, 2,4-hexadienyl, and the like. By alkynyl is meant straight chain, branched or cyclic alkynes, such as ethynyl, propynyl, propargyl and the like.

所谓的烷氧基是指直链、支链或环状链烷基,经氧原子键连接到结构上。卤代烷氧基是指烷氧基被一个或多个卤原子取代的基团,例如,氯甲氧基、二氯甲氧基、三氯甲氧基、氟甲氧基、二氟甲氧基、三氟甲氧基、氯氟甲氧基等。烯氧基是指直链、支链或环状链烯基,经氧原子键连接到结构上。卤代烯氧基是指烯氧基被一个或多个卤原子取代的基团。炔氧基是指直链、支链或环状链炔基,经氧原子键连接到结构上。卤代炔氧基是指炔氧基被一个或多个卤原子取代的基团。By alkoxy is meant a straight, branched or cyclic alkyl group attached to the structure via an oxygen atom bond. Haloalkoxy refers to an alkoxy group substituted with one or more halogen atoms, for example, chloromethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, Trifluoromethoxy, chlorofluoromethoxy, etc. Alkenyloxy refers to a straight, branched or cyclic alkenyl group attached to the structure through an oxygen atom bond. Haloalkenyloxy refers to a group in which an alkenyloxy group is substituted with one or more halogen atoms. Alkynyloxy refers to a straight, branched or cyclic alkynyl group bonded to the structure through an oxygen atom bond. Haloalkynyloxy refers to a group in which the alkynyloxy group is substituted with one or more halogen atoms.

所谓的烷硫基是指直链、支链或环状链烷基,经硫原子键连接到结构上。卤代烷硫基是指烷硫基被一个或多个卤原子取代的基团,例如,氯甲硫基、二氯甲硫基、三氯甲硫基、氟甲硫基、二氟甲硫基、三氟甲硫基、氯氟甲硫基等。烯硫基是指直链、支链或环状链烯基,经硫原子键连接到结构上。卤代烯硫基是指烯氧基被一个或多个卤原子取代的基团。炔硫基是指直链、支链或环状链炔基,经硫原子键连接到结构上。卤代炔硫基是指炔硫基被一个或多个卤原子取代的基团。The so-called alkylthio group refers to a straight chain, branched chain or cyclic chain alkyl group, which is attached to the structure through a sulfur atom bond. Haloalkylthio refers to a group in which an alkylthio group is substituted with one or more halogen atoms, for example, chloromethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, Trifluoromethylthio, chlorofluoromethylthio, etc. Alkenylthio refers to a straight, branched or cyclic alkenyl group attached to the structure through a sulfur atom bond. Haloalkenylthio refers to a group in which an alkenyloxy group is substituted with one or more halogen atoms. Alkynylthio refers to a straight, branched or cyclic alkynyl group attached to the structure via a sulfur atom bond. A haloalkynylthio group refers to a group in which the alkynylthio group is substituted with one or more halogen atoms.

所谓的羟基烷基、巯基烷基和醛基烷基分别是指烷基被一个或多个羟基、巯基和醛基取代的基团。羟基烯基、巯基烯基和醛基烯基分别是指烯基被一个或多个羟基、巯基和醛基取代的基团。羟基炔基、巯基炔基和醛基炔基是指炔基被一个或多个羟基、巯基和醛基取代的基团。The so-called hydroxyalkyl, mercaptoalkyl and aldehyde alkyl groups refer to groups in which the alkyl group is substituted with one or more hydroxy, mercapto and aldehyde groups, respectively. Hydroxyalkenyl, mercaptoalkenyl, and aldehyde alkenyl refer to groups in which an alkenyl group is substituted with one or more hydroxy, mercapto, and aldehyde groups, respectively. Hydroxyalkynyl, mercaptoalkynyl, and aldehyde alkynyl refer to groups in which an alkynyl group is substituted with one or more hydroxy, mercapto, and aldehyde groups.

所谓的羰基氨基是指-CO-NH-结构,磺酰基氨基是指-SO2-NH-结构,亚磺酰基氨基是指-SO-NH-结构,硫代羰基氨基是指-CS-NH-结构。氨基羰基是指-NH-CO-结构,氨基磺酰基是指-NH-SO2-结构,氨基亚磺酰基是指-NH-SO-结构,氨基硫代羰基是指-NH-CS-结构。The so-called carbonylamino refers to the -CO-NH- structure, the sulfonylamino refers to the -SO 2 -NH- structure, the sulfinylamino refers to the -SO-NH- structure, and the thiocarbonylamino refers to the -CS-NH- structure. Aminocarbonyl refers to the -NH-CO- structure, aminosulfonyl refers to the -NH-SO 2 - structure, aminosulfinyl refers to the -NH-SO- structure, and aminothiocarbonyl refers to the -NH-CS- structure.

所谓的碳芳基是指以未取代或被1~4个基团取代的碳原子构成的多元芳香基团,例如,1-甲基苯基、2-丙基萘基等。杂环基是指未取代或被1~4个基团取代的含1个或多个N、O、S杂原子的五元环或六元环。例如氧硫杂环、吗啉、吡喃、吡啶、嘧啶、哒嗪、喹啉、吡唑、噻唑、异噻唑、噻二唑、噻吩、呋喃、噁唑、异噁唑、噁二唑,以及这些杂环含卤素(氟、氯、溴、碘)的衍生物。The so-called carboaryl group refers to a polyvalent aromatic group composed of unsubstituted or 1-4 groups of carbon atoms, for example, 1-methylphenyl, 2-propylnaphthyl and the like. Heterocyclyl refers to a five-membered or six-membered ring containing one or more N, O, S heteroatoms that is unsubstituted or substituted by 1 to 4 groups. For example, oxthiane, morpholine, pyran, pyridine, pyrimidine, pyridazine, quinoline, pyrazole, thiazole, isothiazole, thiadiazole, thiophene, furan, oxazole, isoxazole, oxadiazole, and These heterocycles contain derivatives of halogens (fluorine, chlorine, bromine, iodine).

本发明的部分化合物可以用表1~3中列出来的具体化合物来说明,本发明包括但不仅限于这些化合物。Part of the compounds of the present invention can be illustrated by the specific compounds listed in Tables 1-3, and the present invention includes but is not limited to these compounds.

Figure BDA0002383090810000091
Figure BDA0002383090810000091

表1Table 1

Figure BDA0002383090810000092
Figure BDA0002383090810000092

Figure BDA0002383090810000101
Figure BDA0002383090810000101

Figure BDA0002383090810000102
Figure BDA0002383090810000102

表2Table 2

Figure BDA0002383090810000103
Figure BDA0002383090810000103

Figure BDA0002383090810000111
Figure BDA0002383090810000111

Figure BDA0002383090810000121
Figure BDA0002383090810000121

表3table 3

Figure BDA0002383090810000122
Figure BDA0002383090810000122

Figure BDA0002383090810000131
Figure BDA0002383090810000131

Figure BDA0002383090810000141
Figure BDA0002383090810000141

本发明通式(I)化合物通常可由溴代苯甲醛或溴代苯甲酸类化合物I-1或氰基取代的溴代甲苯类化合物I-2与氯甲基甲醚反应,转换为羟基被甲氧基甲基保护的溴代苯甲醇类化合物I-3,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,最后在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物I-4,合成路线下:The compound of general formula (I) of the present invention can usually be reacted with bromobenzaldehyde or bromobenzoic acid compound I-1 or cyano-substituted bromotoluene compound I-2 with chloromethyl methyl ether to convert the hydroxyl group to methyl ether. Oxymethyl-protected bromobenzyl alcohol compound I-3, and then reacted with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to connect the boron atom to the benzene ring, and finally deprotected in hydrochloric acid, The corresponding benzoxaborol-1-ol compound I-4 is obtained by spontaneous cyclization. The synthetic route is as follows:

Figure BDA0002383090810000151
Figure BDA0002383090810000151

本发明通式(II)化合物,当Y选自CH2时通常可由溴代苯甲醛类化合物II-5发生维蒂希反应经水解后得到溴代苯乙醛类化合物II-6,再与氯甲基甲醚反应,得到羟基被甲氧基甲基保护的溴代苯乙醇类化合物II-7,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的六元苯并氧杂硼-1-醇类化合物II-8,合成路线如下:In the compound of general formula (II) of the present invention, when Y is selected from CH 2 , bromobenzaldehyde compounds II-5 can usually be subjected to Wittig reaction and hydrolyzed to obtain bromobenzaldehyde compounds II-6, which are then combined with chlorine Reaction with methyl methyl ether to obtain bromophenethyl alcohol compound II-7 whose hydroxyl group is protected by methoxymethyl group, and finally react with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to connect the boron atom to the compound II-7. On the benzene ring, deprotection in hydrochloric acid, spontaneous ring formation to obtain the corresponding six-membered benzoxaborol-1-ol compound II-8, the synthetic route is as follows:

Figure BDA0002383090810000152
Figure BDA0002383090810000152

本发明通式(Ⅲ)化合物,当R3为被取代的苯基时可以用如下方法合成。The compound of the general formula (III) of the present invention, when R3 is a substituted phenyl group, can be synthesized by the following method.

L为S、O时,通常可由(硫)酚类化合物Ⅲ-9和Ⅲ-10反应得到(硫)醚类化合物Ⅲ-11,再经硼氢化钠还原得Ⅲ-12。然后Ⅲ-12与氯甲基甲醚反应得Ⅲ-13,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物Ⅲ-14。Ⅲ-14也可由Ⅲ-11在钯的催化下与双联频哪醇基二硼反应得Ⅲ-15水解还原得到,合成路线如下:When L is S, O, (thio) phenolic compounds III-9 and III-10 can usually be reacted to obtain (thio) ether compounds III-11, which are then reduced by sodium borohydride to obtain III-12. Then III-12 was reacted with chloromethyl methyl ether to obtain III-13, and finally it was reacted with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to connect the boron atom to the benzene ring, and deprotected in hydrochloric acid. Spontaneous ring formation gave the corresponding benzoxaborol-1-ols III-14. III-14 can also be obtained by the hydrolysis and reduction of III-15 by reacting III-11 with double pinacol-based diboron under the catalysis of palladium. The synthetic route is as follows:

Figure BDA0002383090810000161
Figure BDA0002383090810000161

L为硫代羰基、磺酰基的苯并氧杂硼-1-醇类化合物可由相应的化合物Ⅲ-14经高碘酸钠氧化分别得到化合物Ⅲ-16和Ⅲ-17,合成路线如下:The benzoxaborol-1-ol compounds in which L is a thiocarbonyl group and a sulfonyl group can be oxidized by the corresponding compound III-14 with sodium periodate to obtain compounds III-16 and III-17, respectively. The synthetic route is as follows:

Figure BDA0002383090810000162
Figure BDA0002383090810000162

L为羰基时,取代苯或杂环类化合物Ⅲ-18和Ⅲ-19发生傅克反应得化合物Ⅲ-20,然后经溴代丁二酰亚胺溴代、与醋酸钠在碱性条件下水解得化合物Ⅲ-21氧化得化合物Ⅲ-22,然后与乙二醇反应的化合物Ⅲ-23,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的化合物Ⅲ-25,最后用沙瑞特试剂反应得苯并氧杂硼-1-醇类化合物Ⅲ-26,合成路线如下:When L is carbonyl, substituted benzene or heterocyclic compounds III-18 and III-19 undergo Friedel-Crafts reaction to obtain compound III-20, which is then brominated with bromosuccinimide and hydrolyzed with sodium acetate under alkaline conditions Compound III-21 is oxidized to obtain compound III-22, then compound III-23 reacted with ethylene glycol, and then reacted with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to connect the boron atom to the benzene ring , deprotected in hydrochloric acid, and spontaneously formed a ring to obtain the corresponding compound III-25. Finally, the benzoxaborol-1-ol compound III-26 was obtained by reacting with Saret reagent. The synthetic route is as follows:

Figure BDA0002383090810000171
Figure BDA0002383090810000171

L为羰基氨基、硫代羰基氨基、磺酰基氨基时,化合物Ⅲ-27与不同的酰氯、硫代酰氯、磺酰氯偶联形成由L连接的苯并氧杂硼-1-醇类化合物Ⅲ-28、Ⅲ-29、Ⅲ-30,合成路线如下:When L is carbonylamino, thiocarbonylamino and sulfonylamino, compound III-27 is coupled with different acid chlorides, thioacyl chlorides and sulfonyl chlorides to form benzoxaborol-1-ol compounds III- 28, Ⅲ-29, Ⅲ-30, the synthetic route is as follows:

Figure BDA0002383090810000172
Figure BDA0002383090810000172

L为NH时,通常可由碘代化合物Ⅲ-31和化合物Ⅲ-32,在叔丁氧羰基保护下形成醇类化合物Ⅲ-35,然后再与3,4-二氢吡喃在吡啶的存在下,形成四氢吡喃保护的醇羟基,最后在酸性条件下脱保护并形成Ⅲ-39,合成路线如下:When L is NH, the alcohol compound III-35 can be formed by iodine compound III-31 and compound III-32 under the protection of tert-butoxycarbonyl group, and then combined with 3,4-dihydropyran in the presence of pyridine , forming the alcoholic hydroxyl group protected by tetrahydropyran, and finally deprotected under acidic conditions to form III-39. The synthetic route is as follows:

Figure BDA0002383090810000181
Figure BDA0002383090810000181

L为CH2时,通常可由硼酸类化合物Ⅲ-40和2-甲氧基-4-溴苯甲醛Ⅲ-41发生Suzuki偶联反应得到Ⅲ-42,再经三氟磺酸酐在三氯化铈和碘化钠作用下转化成三氟甲基磺酸盐Ⅲ-44,经硼烷化后,最终在酸性条件下水解得相应的苯并氧杂硼-1-醇类化合物Ⅲ-46,合成路线如下:L is CH It is converted into trifluoromethanesulfonate III-44 under the action of sodium iodide, and finally hydrolyzed under acidic conditions to obtain the corresponding benzoxaborol-1-ol compound III-46 after boranization. The route is as follows:

Figure BDA0002383090810000182
Figure BDA0002383090810000182

本发明提供的如式(I)~(Ⅲ)所示结构的苯并氧杂硼-1-醇类化合物具有杀菌的作用,对农作物病菌如早疫病菌、赤霉病菌、纹枯病菌、灰霉病菌、斑点病菌、炭疽病菌等都有明显的抑制作用。The benzoxaborol-1-ol compounds with the structures shown in the formulas (I) to (III) provided by the present invention have bactericidal effect, and are effective against crop pathogens such as early blight, scab, sheath blight, Botrytis cinerea, spot bacteria, anthracnose, etc. have obvious inhibitory effects.

具体实施方式Detailed ways

以下对本发明的具体实施方式进行详细说明。应当理解的是,此处所描述的具体实施方式仅用于说明和解释本发明,并不用于限制本发明。Specific embodiments of the present invention will be described in detail below. It should be understood that the specific embodiments described herein are only used to illustrate and explain the present invention, but not to limit the present invention.

实施例1化合物1的制备Preparation of Example 1 Compound 1

化合物1的制备方法,包括以下步骤:The preparation method of compound 1, comprises the following steps:

步骤A:2-溴-5-氟苯甲醇的制备Step A: Preparation of 2-bromo-5-fluorobenzyl alcohol

取2-溴-5-氟苯甲醛(62.0g,293mmol)溶于甲醇(400mL),于0℃分批加入硼氢化钠(5.57g,147mmol)。室温下搅拌1h后,加入水,减压蒸馏除去一半的溶剂,用乙酸乙酯、水萃取体系萃取,有机层用饱和食盐水洗涤,再用无水硫酸钠干燥,脱去溶剂得2-溴-5-氟苯甲醇。2-Bromo-5-fluorobenzaldehyde (62.0 g, 293 mmol) was dissolved in methanol (400 mL), and sodium borohydride (5.57 g, 147 mmol) was added in portions at 0°C. After stirring at room temperature for 1 h, water was added, half of the solvent was removed by distillation under reduced pressure, extracted with ethyl acetate and water extraction system, the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and the solvent was removed to obtain 2-bromo -5-Fluorobenzyl alcohol.

Figure BDA0002383090810000191
Figure BDA0002383090810000191

步骤B:1-溴-4-氟-2-((甲氧基甲氧基)甲基)苯的制备Step B: Preparation of 1-bromo-4-fluoro-2-((methoxymethoxy)methyl)benzene

取2-溴-5-氟苯甲醇(60.8g,293mmol)以及二异丙基乙胺(61mL,0.35mol)溶于二氯甲烷中,于0℃加入氯甲基甲醚(27mL,0.35mol)后,过夜于室温下搅拌。加入水,混合物用三氯甲烷萃取,有机层用饱和氯化钠洗涤,再以无水硫酸钠干燥。加压蒸馏脱去溶剂得1-溴-4-氟-2-((甲氧基甲氧基)甲基)苯。Dissolve 2-bromo-5-fluorobenzyl alcohol (60.8g, 293mmol) and diisopropylethylamine (61mL, 0.35mol) in dichloromethane, add chloromethyl methyl ether (27mL, 0.35mol) at 0°C ) and stirred at room temperature overnight. Water was added, the mixture was extracted with chloroform, and the organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. Pressurized distillation to remove the solvent to obtain 1-bromo-4-fluoro-2-((methoxymethoxy)methyl)benzene.

Figure BDA0002383090810000192
Figure BDA0002383090810000192

步骤C:中间体2-((甲氧基甲氧基)甲基)-4-氟苯硼酸的制备Step C: Preparation of Intermediate 2-((methoxymethoxy)methyl)-4-fluorophenylboronic acid

取1-溴-4-氟-2-((甲氧基甲氧基)甲基)苯(73.2g,293mmol)溶于四氢呋喃(400mL)中,在45min内,于-78℃加入正丁基锂(1.6M溶于己烷中,200mL)。5min后,硼酸三异丙酯(76.0mL,330mmol)在10min内加入完毕,反应1.5h后,得到中间体混合物。1-Bromo-4-fluoro-2-((methoxymethoxy)methyl)benzene (73.2 g, 293 mmol) was dissolved in tetrahydrofuran (400 mL), and n-butyl was added at -78°C within 45 min Lithium (1.6M in hexanes, 200 mL). After 5 min, triisopropyl borate (76.0 mL, 330 mmol) was added in 10 min, and the intermediate mixture was obtained after 1.5 h of reaction.

Figure BDA0002383090810000193
Figure BDA0002383090810000193

步骤D:化合物1的制备Step D: Preparation of Compound 1

向上述中间体混合物中加入水和盐酸(6M,55mL),减压蒸馏至溶剂减少一半。混合物用乙酸乙酯及水萃取后,有机层用饱和氯化钠洗涤并用无水硫酸钠干燥。减压蒸馏脱溶后,用异丙醚/己烷处理残留物,得白色粉末状化合物1(26.9g,产率60%),熔点:118-120℃。1H NMR(400MHz,DMSO-d6)δ(ppm):9.22(s,1H),7.75(dd,J=8.0,5.9Hz,1H),7.24(dd,J=9.5,1.8Hz,1H),7.19–7.12(m,1H),4.96(s,2H)。Water and hydrochloric acid (6M, 55 mL) were added to the above intermediate mixture and distilled under reduced pressure until the solvent was reduced by half. After the mixture was extracted with ethyl acetate and water, the organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. After precipitation by distillation under reduced pressure, the residue was treated with isopropyl ether/hexane to obtain compound 1 (26.9 g, yield 60%) as white powder, melting point: 118-120°C. 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 9.22 (s, 1H), 7.75 (dd, J=8.0, 5.9 Hz, 1H), 7.24 (dd, J=9.5, 1.8 Hz, 1H) , 7.19–7.12 (m, 1H), 4.96 (s, 2H).

Figure BDA0002383090810000201
Figure BDA0002383090810000201

化合物2~12的合成均可参照实施例1化合物1的制备方法得到,其中化合物2-4苯环上取代基分别为6-F,5-Cl和H。The synthesis of compounds 2-12 can be obtained by referring to the preparation method of compound 1 in Example 1, wherein the substituents on the benzene ring of compounds 2-4 are 6-F, 5-Cl and H, respectively.

实施例2化合物13的制备Preparation of Example 2 Compound 13

化合物13的制备方法,包括以下步骤:The preparation method of compound 13, comprises the following steps:

步骤A:2-溴-5-氟苯乙醛的制备Step A: Preparation of 2-bromo-5-fluorophenylacetaldehyde

取2-溴-5-氟-苯甲醛(4.2g,20.0mmol)、甲氧基甲基三苯基氯化膦(8.5g,24.0mmol)以及叔丁基醇钾(2.8g,24.0mol)溶于N,N-二甲基甲酰胺(50mL),在室温下过夜搅拌。反应用盐酸(6M)中止反应,混合物用乙酸乙酯萃取。有机层用水洗涤两次以及用饱和氯化钠洗涤一次,最后用无水硫酸钠干燥。减压蒸馏脱去溶剂后,向残留物中加入四氢呋喃(60mL)和盐酸(6M),再加热回流8h。向混合物中加入水、乙醚萃取之,有机层用饱和氯化钠洗涤并用无水硫酸钠干燥。最后,减压蒸馏脱溶得2-溴-5-氟苯乙醛。Take 2-bromo-5-fluoro-benzaldehyde (4.2g, 20.0mmol), methoxymethyltriphenylphosphine chloride (8.5g, 24.0mmol) and potassium tert-butylate (2.8g, 24.0mol) Dissolve in N,N-dimethylformamide (50 mL) and stir at room temperature overnight. The reaction was quenched with hydrochloric acid (6M), and the mixture was extracted with ethyl acetate. The organic layer was washed twice with water and once with saturated sodium chloride, and finally dried over anhydrous sodium sulfate. After the solvent was evaporated under reduced pressure, tetrahydrofuran (60 mL) and hydrochloric acid (6 M) were added to the residue, and the mixture was heated under reflux for 8 h. Water and ether were added to the mixture for extraction, and the organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. Finally, 2-bromo-5-fluorophenylacetaldehyde is obtained by desolvation by distillation under reduced pressure.

Figure BDA0002383090810000202
Figure BDA0002383090810000202

步骤B:2-((甲氧基甲氧基)乙基)-1-溴-4-氟苯的制备Step B: Preparation of 2-((methoxymethoxy)ethyl)-1-bromo-4-fluorobenzene

取2-溴-5-氟苯乙醛(3.6g,16.6mmol)溶于甲醇(40mL),于0℃加入硼氢化钠(640mg,16.6mmol)并于室温下搅拌1h。加水至混合物中,并用乙酸乙酯萃取之。有机层用饱和氯化钠洗涤并用无水硫酸钠干燥。经减压蒸馏脱溶后,向残留物中于0℃加入二氯甲烷(50mL)、二异丙基乙胺(3.5mL,20mmol)和氯甲基甲醚(1.5mL,20mmol),反应体系在室温下搅拌过夜。再向混合物中加入水、氯仿萃取之,有机层用饱和氯化钠洗涤并用无水硫酸钠干燥。经减压蒸馏脱溶后,产物用硅胶柱层析得到无色油状的2-((甲氧基甲氧基)乙基)-1-溴-4-氟苯。2-Bromo-5-fluorophenylacetaldehyde (3.6 g, 16.6 mmol) was dissolved in methanol (40 mL), sodium borohydride (640 mg, 16.6 mmol) was added at 0° C. and stirred at room temperature for 1 h. Water was added to the mixture, and it was extracted with ethyl acetate. The organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. After desolvation by distillation under reduced pressure, dichloromethane (50 mL), diisopropylethylamine (3.5 mL, 20 mmol) and chloromethyl methyl ether (1.5 mL, 20 mmol) were added to the residue at 0°C, and the reaction system was Stir overnight at room temperature. Water was added to the mixture, followed by extraction with chloroform, and the organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. After desolvation by distillation under reduced pressure, the product was subjected to silica gel column chromatography to obtain 2-((methoxymethoxy)ethyl)-1-bromo-4-fluorobenzene as a colorless oil.

Figure BDA0002383090810000211
Figure BDA0002383090810000211

步骤C:化合物13的制备Step C: Preparation of Compound 13

取2-((甲氧基甲氧基)乙基)-1-溴-4-氟苯(7.3g,29.3mmol)溶于四氢呋喃(40mL)中,在45min内,于-78℃加入正丁基锂(1.6M溶于己烷中,20mL)。5min后,硼酸三异丙酯(7.60mL,33.0mmol)在10min内加入完毕,经过1.5h后混合物恢复到室温。加入水和盐酸(6M,55mL),减压蒸馏至溶剂减少一半。混合物用乙酸乙酯及水萃取后,有机层用饱和氯化钠洗涤并用无水硫酸钠干燥。减压蒸馏脱溶后,硅胶柱层析纯化产物(己烷:乙酸乙酯=2:1),将粗产品分散至戊烷中,搅碎后过滤得白色的固体产物化合物13(1.0g,产率:21%),熔点:77-82℃。1H NMR(300MHz,DMSO-d6)δ(ppm):2.86(t,J=5.9Hz,2H),4.04(t,J=5.9Hz,2H),7.0-7.1(m,2H),7.69(dd,J=8.2,7.2Hz,1H),8.47(s,1H)。2-((methoxymethoxy)ethyl)-1-bromo-4-fluorobenzene (7.3 g, 29.3 mmol) was dissolved in tetrahydrofuran (40 mL), and n-butyl was added at -78°C within 45 min Lithium (1.6M in hexanes, 20 mL). After 5 min, triisopropyl borate (7.60 mL, 33.0 mmol) was added in 10 min, and the mixture returned to room temperature after 1.5 h. Water and hydrochloric acid (6M, 55 mL) were added and distilled under reduced pressure until the solvent was reduced by half. After the mixture was extracted with ethyl acetate and water, the organic layer was washed with saturated sodium chloride and dried over anhydrous sodium sulfate. After desolvation by distillation under reduced pressure, the product was purified by silica gel column chromatography (hexane:ethyl acetate=2:1), the crude product was dispersed in pentane, and after stirring, a white solid product Compound 13 (1.0 g, Yield: 21%), melting point: 77-82°C. 1 H NMR (300 MHz, DMSO-d 6 ) δ (ppm): 2.86 (t, J=5.9 Hz, 2H), 4.04 (t, J=5.9 Hz, 2H), 7.0-7.1 (m, 2H), 7.69 (dd, J=8.2, 7.2 Hz, 1H), 8.47 (s, 1H).

Figure BDA0002383090810000213
Figure BDA0002383090810000213

化合物14和化合物15的合成均可参照实施例2化合物13的制备方法得到。The synthesis of compound 14 and compound 15 can be obtained by referring to the preparation method of compound 13 in Example 2.

实施例3化合物25的制备Example 3 Preparation of Compound 25

化合物25的制备方法,包括以下步骤:The preparation method of compound 25, comprises the following steps:

步骤A:4-((3,4-二氯苯基)硫基)-2-溴苯甲醛的制备Step A: Preparation of 4-((3,4-Dichlorophenyl)thio)-2-bromobenzaldehyde

取2-溴-4-氟苯甲醛(1.0g,4.92mmol)溶于N,N-二甲基甲酰胺(25mL),用冰水浴冷却至0℃。在氮气保护下,依次加入碳酸钾(2.0g,9.85mmol)和3,4-二氯苯硫醇(882mg,4.92mmol)。继续搅拌混合物2.5h后,再用冰水(25mL)处理。用乙酸乙酯萃取后,有机层用水和饱和氯化钠洗涤,再以无水硫酸钠干燥。残留物用旋转蒸发仪脱溶,硅胶柱层析纯化产物得4-((3,4-二氯苯基)硫基)-2-溴苯甲醛纯品。2-Bromo-4-fluorobenzaldehyde (1.0 g, 4.92 mmol) was dissolved in N,N-dimethylformamide (25 mL), and cooled to 0 °C with an ice-water bath. Under nitrogen protection, potassium carbonate (2.0 g, 9.85 mmol) and 3,4-dichlorobenzenethiol (882 mg, 4.92 mmol) were added sequentially. After stirring the mixture for a further 2.5 h, it was treated with ice water (25 mL). After extraction with ethyl acetate, the organic layer was washed with water and saturated sodium chloride, and dried over anhydrous sodium sulfate. The residue was removed by rotary evaporator, and the product was purified by silica gel column chromatography to obtain pure 4-((3,4-dichlorophenyl)sulfanyl)-2-bromobenzaldehyde.

Figure BDA0002383090810000212
Figure BDA0002383090810000212

步骤B:4-((3,4-二氯苯基)硫基)-2-溴苯甲醇的制备Step B: Preparation of 4-((3,4-Dichlorophenyl)thio)-2-bromobenzyl alcohol

取4-((3,4-二氯苯基)硫基)-2-溴苯甲醛(400mg,1.10mmol)溶于甲醇(20mL)并用冰水浴冷却至0℃,向溶液中加入硼氢化钠(62mg,1.65mmol)。将反应物搅拌0.5h,然后加入饱和的碳酸氢钠。将反应混合物脱溶后,用乙酸乙酯萃取,分别用水和饱和氯化钠洗涤,最后用无水硫酸钠干燥,真空浓缩得黏稠油状产物4-((3,4-二氯苯基)硫基)-2-溴苯甲醇。Dissolve 4-((3,4-dichlorophenyl)sulfanyl)-2-bromobenzaldehyde (400 mg, 1.10 mmol) in methanol (20 mL) and cool it to 0°C with an ice-water bath, add sodium borohydride to the solution (62 mg, 1.65 mmol). The reaction was stirred for 0.5 h, then saturated sodium bicarbonate was added. After the reaction mixture was desolubilized, extracted with ethyl acetate, washed with water and saturated sodium chloride respectively, finally dried with anhydrous sodium sulfate, and concentrated in vacuo to obtain 4-((3,4-dichlorophenyl)sulfur as a viscous oily product base)-2-bromobenzyl alcohol.

Figure BDA0002383090810000221
Figure BDA0002383090810000221

步骤C:(4-(甲氧基甲氧基)甲基)-3-溴苯基)(3,4-二氯苯基)硫醚的制备Step C: Preparation of (4-(methoxymethoxy)methyl)-3-bromophenyl)(3,4-dichlorophenyl)sulfide

取4-((3,4-二氯苯基)硫基)-2-溴苯甲醇(4.3g,11.84mmol)溶于无水二氯甲烷(50mL)中,在氮气保护下,依次加入N,N-二异丙基乙胺(7.32mL,41.45mmol)和氯甲基甲醚(1.91mL,26.05mmol)。将混合物于室温下过夜搅拌并用水(15mL)处理,再用二氯甲烷萃取后,有机层用水和饱和氯化钠洗涤后,最后用无水硫酸铵干燥。残留物经旋转蒸发仪脱溶后,再用硅胶柱层析纯化得到黏稠油状产物(4-(甲氧基甲氧基)甲基)-3-溴苯基)(3,4-二氯苯基)硫醚。Dissolve 4-((3,4-dichlorophenyl)sulfanyl)-2-bromobenzyl alcohol (4.3 g, 11.84 mmol) in anhydrous dichloromethane (50 mL), under nitrogen protection, add N successively , N-diisopropylethylamine (7.32 mL, 41.45 mmol) and chloromethyl methyl ether (1.91 mL, 26.05 mmol). The mixture was stirred at room temperature overnight and treated with water (15 mL), and after extraction with dichloromethane, the organic layer was washed with water and saturated sodium chloride, and finally dried over anhydrous ammonium sulfate. The residue was desolubilized by rotary evaporator and purified by silica gel column chromatography to obtain (4-(methoxymethoxy)methyl)-3-bromophenyl)(3,4-dichlorobenzene) as a viscous oily product. base) thioether.

Figure BDA0002383090810000222
Figure BDA0002383090810000222

步骤D:化合物25的制备Step D: Preparation of Compound 25

取(4-(甲氧基甲氧基)甲基)-3-溴苯基)(3,4-二氯苯基)硫醚(2.4g,5.86mmol)溶于无水四氢呋喃(25mL)并冷却至-80℃。在氮气保护下,在20min内向溶液中滴加正丁基锂(1.6M,4.03mL,6.45mmol)。反应物于-80℃搅拌20min后,滴加硼酸三异丙酯(1.48mL,6.45mmol)。待反应混合物逐渐恢复至室温并于室温下过夜搅拌后,加入盐酸(6M,20mL)搅拌3h。混合物脱溶后用乙酸乙酯萃取,最后用无水硫酸钠干燥。残留物经旋转蒸发仪脱溶后,再用硅胶柱层析纯化得到化合物25(608mg,产率:33.3%),熔点:118-119℃。1H NMR(400MHz,DMSO-d6)δ(ppm):9.28(s,1H),7.81(s,1H),7.60-7.45(m,4H),7.15(dd,J=8.4,2.0Hz,1H),5.03(s,2H)。Dissolve (4-(methoxymethoxy)methyl)-3-bromophenyl)(3,4-dichlorophenyl)sulfide (2.4 g, 5.86 mmol) in dry tetrahydrofuran (25 mL) and Cool to -80°C. Under nitrogen protection, n-butyllithium (1.6 M, 4.03 mL, 6.45 mmol) was added dropwise to the solution over 20 min. After the reaction was stirred at -80°C for 20 min, triisopropyl borate (1.48 mL, 6.45 mmol) was added dropwise. After the reaction mixture was gradually returned to room temperature and stirred at room temperature overnight, hydrochloric acid (6M, 20 mL) was added and stirred for 3 h. The mixture was desolubilized, extracted with ethyl acetate, and finally dried over anhydrous sodium sulfate. The residue was desolubilized by a rotary evaporator, and then purified by silica gel column chromatography to obtain compound 25 (608 mg, yield: 33.3%), melting point: 118-119°C. 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 9.28 (s, 1H), 7.81 (s, 1H), 7.60-7.45 (m, 4H), 7.15 (dd, J=8.4, 2.0 Hz, 1H), 5.03 (s, 2H).

Figure BDA0002383090810000231
Figure BDA0002383090810000231

化合物26、27的合成均可参照实施例3化合物25的制备方法得到。The synthesis of compounds 26 and 27 can be obtained by referring to the preparation method of compound 25 in Example 3.

实施例4化合物28的制备Example 4 Preparation of Compound 28

取化合物25(200mg,0.64mmol)溶于水:甲醇(1:10)(15mL),加入高碘酸钠(688mg,3.21mmol),于60℃搅拌1h后,蒸去溶剂并用乙酸乙酯萃取。有机层用水和饱和氯化钠洗涤,以无水硫酸钠干燥。粗产品经旋蒸后,重结晶纯化得化合物28(112.4mg,产率:53.5%),熔点:141-143℃。1H NMR(400MHz,DMSO-d6)δ(ppm):9.39(s,1H),8.11(s,1H),7.99(d,J=2.0Hz,1H),7.88-7.81(m,2H),7.69-7.60(m,2H),5.02(s,2H)。Dissolve compound 25 (200 mg, 0.64 mmol) in water: methanol (1:10) (15 mL), add sodium periodate (688 mg, 3.21 mmol), stir at 60 °C for 1 h, evaporate the solvent and extract with ethyl acetate . The organic layer was washed with water and saturated sodium chloride, and dried over anhydrous sodium sulfate. After the crude product was rotary evaporated, recrystallized and purified to obtain compound 28 (112.4 mg, yield: 53.5%), melting point: 141-143°C. 1 H NMR (400MHz, DMSO-d 6 ) δ(ppm): 9.39(s, 1H), 8.11(s, 1H), 7.99(d, J=2.0Hz, 1H), 7.88-7.81(m, 2H) , 7.69-7.60 (m, 2H), 5.02 (s, 2H).

Figure BDA0002383090810000232
Figure BDA0002383090810000232

化合物29、30的合成均可参照实施例4化合物28的制备方法得到。The synthesis of compounds 29 and 30 can be obtained by referring to the preparation method of compound 28 in Example 4.

实施例5化合物31的制备Example 5 Preparation of Compound 31

取化合物25(260mg,0.83mmol)溶于水:甲醇(1:10)(15mL),加入高碘酸钠(894mg,4.17mmol),于60℃过夜搅拌后蒸去溶剂,以乙酸乙酯萃取。有机层用水和饱和氯化钠洗涤,以无水硫酸钠干燥。粗产品经旋蒸后,重结晶纯化得化合物31(86mg,产率:30%),熔点:154-156℃。1H NMR(400MHz,DMSO-d6)δ(ppm):9.49(s,1H),8.35(s,1H),8.20(s,1H),8.12(dd,J=8.4,2.0Hz,1H),7.90(d,2H),7.68(d,1H),5.06(s,2H)。Dissolve compound 25 (260 mg, 0.83 mmol) in water: methanol (1:10) (15 mL), add sodium periodate (894 mg, 4.17 mmol), stir at 60 °C overnight, evaporate the solvent, and extract with ethyl acetate . The organic layer was washed with water and saturated sodium chloride, and dried over anhydrous sodium sulfate. After the crude product was rotary evaporated, recrystallized and purified to obtain compound 31 (86 mg, yield: 30%), melting point: 154-156°C. 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 9.49 (s, 1H), 8.35 (s, 1H), 8.20 (s, 1H), 8.12 (dd, J=8.4, 2.0 Hz, 1H) , 7.90(d, 2H), 7.68(d, 1H), 5.06(s, 2H).

Figure BDA0002383090810000233
Figure BDA0002383090810000233

化合物32、33的合成均可参照实施例5化合物31的制备方法得到。The synthesis of compounds 32 and 33 can be obtained by referring to the preparation method of compound 31 in Example 5.

实施例6化合物34的制备Example 6 Preparation of Compound 34

化合物34的制备方法,包括以下步骤:The preparation method of compound 34, comprises the following steps:

步骤A:4-苯氧基-2-溴苯甲醛的制备Step A: Preparation of 4-phenoxy-2-bromobenzaldehyde

取苯酚(6.95g,73.88mmol)、2-溴-4-氟苯甲醛(15g,73.88mmol)和碳酸钾(18g,0.13mol)溶于DMF(150mL)中,于100℃加热16h。混合物经热过滤后,滤饼以乙酸乙酯洗涤。于50℃用旋转蒸发仪蒸去溶剂,将残留物置于正戊烷中超声并过滤得4-苯氧基-2-溴苯甲醛。Phenol (6.95 g, 73.88 mmol), 2-bromo-4-fluorobenzaldehyde (15 g, 73.88 mmol) and potassium carbonate (18 g, 0.13 mol) were dissolved in DMF (150 mL) and heated at 100° C. for 16 h. After the mixture was filtered hot, the filter cake was washed with ethyl acetate. The solvent was evaporated with a rotary evaporator at 50°C, and the residue was placed in n-pentane and sonicated and filtered to obtain 4-phenoxy-2-bromobenzaldehyde.

Figure BDA0002383090810000241
Figure BDA0002383090810000241

步骤B:4-苯氧基-2-溴苯甲醇的制备Step B: Preparation of 4-phenoxy-2-bromobenzyl alcohol

取4-苯氧基-2-溴苯甲醛(10.5g,37.89mmol)溶于甲醇(300mL),冰水浴冷却下分批加入硼氢化钠(7.2g,190.32mmol)。混合物在室温下过夜搅拌,蒸发除去甲醇。将产物溶于水并用二氯甲烷萃取、干燥及蒸去溶剂得油状的4-苯氧基-2-溴苯甲醇。4-phenoxy-2-bromobenzaldehyde (10.5 g, 37.89 mmol) was dissolved in methanol (300 mL), and sodium borohydride (7.2 g, 190.32 mmol) was added in portions under ice-water cooling. The mixture was stirred overnight at room temperature and the methanol was evaporated. The product was dissolved in water and extracted with dichloromethane, dried and evaporated to give 4-phenoxy-2-bromobenzyl alcohol as an oil.

Figure BDA0002383090810000242
Figure BDA0002383090810000242

步骤C:2-((甲氧基甲氧基)甲基)-5-苯氧基溴苯的制备Step C: Preparation of 2-((methoxymethoxy)methyl)-5-phenoxybromobenzene

取4-苯氧基-2-溴苯甲醇(10.1g,36.18mmol)和N,N-二异丙基乙胺(11mL)溶于二氯甲烷(200mL),于室温下滴加氯甲氧基甲烷(4.1mL)。混合物在氮气保护下于室温过夜搅拌后,用碳酸氢钠洗涤、干燥并蒸去溶剂得黄色油状产物2-((甲氧基甲氧基)甲基)-5-苯氧基溴苯。4-phenoxy-2-bromobenzyl alcohol (10.1g, 36.18mmol) and N,N-diisopropylethylamine (11mL) were dissolved in dichloromethane (200mL), and chloromethoxy was added dropwise at room temperature base methane (4.1 mL). The mixture was stirred overnight at room temperature under nitrogen, washed with sodium bicarbonate, dried and evaporated to give the product 2-((methoxymethoxy)methyl)-5-phenoxybromobenzene as a yellow oil.

Figure BDA0002383090810000243
Figure BDA0002383090810000243

步骤D:化合物34的制备Step D: Preparation of Compound 34

取2-((甲氧基甲氧基)甲基)-5-苯氧基溴苯(11.7g,36.18mmol)和硼酸三异丙酯(9.6mL,41.60mmol)在氮气保护下溶于四氢呋喃,混合物冷却至-78℃,滴加正丁基锂(1.6M溶于己烷中,26mL)。移去冰水浴,反应混合物继续搅拌3h。加入盐酸(6M,20mL),浓缩溶剂。将残留物溶于甲醇和盐酸(6M)并回流1.5h,蒸去甲醇后用乙酸乙酯萃取。产物经干燥蒸去溶剂后,用硅胶柱层析纯化,以己烷:乙酸乙酯(2:1)为洗脱剂洗脱,得白色固状化合物34(5.1g,产率:62.4%),熔点:95-99℃。1H NMR(300MHz,DMSO-d6)δ(ppm):9.17(s,1H),7.43-7.35(m,3H),7.28(s,1H),7.19-7.09(m,2H),6.99(d,2H),4.96(s,2H)。2-((Methoxymethoxy)methyl)-5-phenoxybromobenzene (11.7 g, 36.18 mmol) and triisopropyl borate (9.6 mL, 41.60 mmol) were dissolved in tetrahydrofuran under nitrogen protection , the mixture was cooled to -78°C, and n-butyllithium (1.6M in hexane, 26mL) was added dropwise. The ice-water bath was removed and the reaction mixture was continued to stir for 3 h. Hydrochloric acid (6M, 20 mL) was added and the solvent was concentrated. The residue was dissolved in methanol and hydrochloric acid (6M) and refluxed for 1.5 h, the methanol was evaporated and extracted with ethyl acetate. After the product was dried and evaporated to remove the solvent, it was purified by silica gel column chromatography, eluted with hexane:ethyl acetate (2:1) as the eluent, to obtain compound 34 (5.1 g, yield: 62.4%) as a white solid. , Melting point: 95-99 ℃. 1 H NMR (300MHz, DMSO-d 6 )δ(ppm): 9.17(s, 1H), 7.43-7.35(m, 3H), 7.28(s, 1H), 7.19-7.09(m, 2H), 6.99( d, 2H), 4.96 (s, 2H).

Figure BDA0002383090810000244
Figure BDA0002383090810000244

化合物35、36的合成均可参照实施例6化合物34的制备方法得到。The synthesis of compounds 35 and 36 can be obtained by referring to the preparation method of compound 34 in Example 6.

实施例7化合物37的制备Example 7 Preparation of Compound 37

化合物37的制备方法,包括以下步骤:The preparation method of compound 37, comprises the following steps:

步骤A:4-苯甲酰基-2-溴甲苯的制备Step A: Preparation of 4-benzoyl-2-bromotoluene

取三氯化铝(1.5g,11.0mmol)溶于苯(16mL),于室温下滴加4-甲基-3-溴苯甲酰氯(2.3g,10.0mmol)的苯溶液(8mL)。混合物于50℃搅拌2h后,用盐酸(3M,20mL)和饱和氯化钠(20mL)洗涤,用无水硫酸钠干燥。产物经旋转蒸发仪除去溶剂后,以硅胶柱层析纯化得4-苯甲酰基-2-溴甲苯。Aluminum trichloride (1.5 g, 11.0 mmol) was dissolved in benzene (16 mL), and a solution of 4-methyl-3-bromobenzoyl chloride (2.3 g, 10.0 mmol) in benzene (8 mL) was added dropwise at room temperature. After the mixture was stirred at 50°C for 2 h, it was washed with hydrochloric acid (3M, 20 mL) and saturated sodium chloride (20 mL), and dried over anhydrous sodium sulfate. After removing the solvent by rotary evaporator, the product was purified by silica gel column chromatography to obtain 4-benzoyl-2-bromotoluene.

Figure BDA0002383090810000251
Figure BDA0002383090810000251

步骤B:4-苯甲酰基-2-溴苯甲醇的制备Step B: Preparation of 4-benzoyl-2-bromobenzyl alcohol

取4-苯甲酰基-2-溴甲苯(2.7g,9.8mmol)于四氯化碳(50mL)中,加入溴代丁二酰亚胺(1.8g,9.8mmol)和过氧化苯甲酰(0.1g,0.5mmol),加热并过夜搅拌。残留物经旋转蒸发仪蒸去溶剂并用硅胶柱层析纯化后得中间产物5-苯甲酰基-2-溴甲基溴苯。再取5-苯甲酰基-2-溴甲基溴苯(1.7g,4.83mmol)于N,N-二甲基甲酰胺(30mL),加入醋酸钠(2.0g,24.15mmol),混合物在60℃下过夜搅拌并加入冰水(50g)。沉淀过滤后,用水洗涤,在真空下干燥得乙酸(4-苯甲酰基-2-溴)苄酯。取乙酸(4-苯甲酰基-2-溴)苄酯(1.6g,4.9mmol)溶于甲醇(25mL),加入氢氧化钠(15%,5mL)并回流1h。混合物蒸去溶剂后,用乙酸乙酯萃取并用无水硫酸钠干燥,经旋转蒸发仪除去溶剂后,再以硅胶柱层析纯化得4-苯甲酰基-2-溴苯甲醇。Take 4-benzoyl-2-bromotoluene (2.7g, 9.8mmol) in carbon tetrachloride (50mL), add bromosuccinimide (1.8g, 9.8mmol) and benzoyl peroxide ( 0.1 g, 0.5 mmol), heated and stirred overnight. The residue was evaporated by rotary evaporator to remove solvent and purified by silica gel column chromatography to obtain the intermediate product 5-benzoyl-2-bromomethylbromobenzene. Then take 5-benzoyl-2-bromomethyl bromobenzene (1.7g, 4.83mmol) in N,N-dimethylformamide (30mL), add sodium acetate (2.0g, 24.15mmol), the mixture is heated at 60 Stir overnight at °C and add ice water (50 g). The precipitate was filtered, washed with water, and dried under vacuum to give (4-benzoyl-2-bromo)benzyl acetate. Dissolve (4-benzoyl-2-bromo)benzyl acetate (1.6 g, 4.9 mmol) in methanol (25 mL), add sodium hydroxide (15%, 5 mL) and reflux for 1 h. After the mixture was evaporated to remove the solvent, it was extracted with ethyl acetate and dried over anhydrous sodium sulfate. After the solvent was removed by a rotary evaporator, it was purified by silica gel column chromatography to obtain 4-benzoyl-2-bromobenzyl alcohol.

Figure BDA0002383090810000252
Figure BDA0002383090810000252

步骤D:4-苯氧基-2-溴苯甲醛的制备Step D: Preparation of 4-phenoxy-2-bromobenzaldehyde

取4-苯甲酰基-2-溴苯甲醇(1.5g,5.15mmol)溶于二氯甲烷(30mL),加入氯铬酸吡啶盐(2.2g,10.3mmol)和硅藻土(2.5g),于室温下过夜搅拌。过滤后,产物经旋转蒸发仪蒸去溶剂并以硅胶柱层析纯化得4-苯氧基-2-溴苯甲醛。Dissolve 4-benzoyl-2-bromobenzyl alcohol (1.5g, 5.15mmol) in dichloromethane (30mL), add pyridinium chlorochromate (2.2g, 10.3mmol) and diatomaceous earth (2.5g), Stir overnight at room temperature. After filtration, the product was evaporated by rotary evaporator to remove solvent and purified by silica gel column chromatography to obtain 4-phenoxy-2-bromobenzaldehyde.

Figure BDA0002383090810000261
Figure BDA0002383090810000261

步骤E:[2-(4-(1,3-二氧戊环-2-基)-3-溴苯基)-2-苯基]-1,3-二氧戊环的制备Step E: Preparation of [2-(4-(1,3-dioxolan-2-yl)-3-bromophenyl)-2-phenyl]-1,3-dioxolane

取4-苯氧基-2-溴苯甲醛(1.3g,4.57mmol)溶于甲苯(50mL),加入乙二醇(2.8g,45.70mmol)和一水合对甲苯磺酸(69mg,0.36mmol),回流96h。混合物用饱和碳酸氢钠、水和饱和氯化钠洗涤,再以无水硫酸钠干燥,蒸去溶剂后得[2-(4-(1,3-二氧戊环-2-基)-3-溴苯基)-2-苯基]-1,3-二氧戊环。Dissolve 4-phenoxy-2-bromobenzaldehyde (1.3g, 4.57mmol) in toluene (50mL), add ethylene glycol (2.8g, 45.70mmol) and p-toluenesulfonic acid monohydrate (69mg, 0.36mmol) , refluxed for 96h. The mixture was washed with saturated sodium bicarbonate, water and saturated sodium chloride, dried over anhydrous sodium sulfate, and the solvent was evaporated to obtain [2-(4-(1,3-dioxolan-2-yl)-3 -bromophenyl)-2-phenyl]-1,3-dioxolane.

Figure BDA0002383090810000262
Figure BDA0002383090810000262

步骤F:(2-甲酰基-5-苯甲酰基)苯基硼酸的制备Step F: Preparation of (2-formyl-5-benzoyl)phenylboronic acid

取[2-(4-(1,3-二氧戊环-2-基)-3-溴苯基)-2-苯基]-1,3-二氧戊环(0.5g,1.23mmol)溶于无水四氢呋喃(10mL),冷却至-80℃。在氮气保护下,在15min内向混合物中滴加正丁基锂(1.6M溶于己烷,0.88mL)。使反应混合物恢复到室温并于室温下过夜搅拌。加入盐酸(6M,6mL)后,继续搅拌2h,蒸去溶剂并以乙酸乙酯萃取、无水硫酸钠干燥。产物蒸去溶剂后,以硅胶柱层析纯化得(2-甲酰基-5-苯甲酰基)苯基硼酸。Take [2-(4-(1,3-dioxolan-2-yl)-3-bromophenyl)-2-phenyl]-1,3-dioxolane (0.5g, 1.23mmol) Dissolve in dry tetrahydrofuran (10 mL) and cool to -80°C. Under nitrogen protection, n-butyllithium (1.6 M in hexane, 0.88 mL) was added dropwise to the mixture over 15 min. The reaction mixture was returned to room temperature and stirred at room temperature overnight. After adding hydrochloric acid (6M, 6 mL), stirring was continued for 2 h, the solvent was evaporated, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After evaporating the solvent, the product was purified by silica gel column chromatography to obtain (2-formyl-5-benzoyl)phenylboronic acid.

Figure BDA0002383090810000263
Figure BDA0002383090810000263

步骤G:[6-(1-苯基-1-羟甲基)]-1,3-二氢-2,1-苯并氧杂硼-1-醇的制备Step G: Preparation of [6-(1-phenyl-1-hydroxymethyl)]-1,3-dihydro-2,1-benzoxaborol-1-ol

取(2-甲酰基-5-苯甲酰基)苯基硼酸(0.8g,2.95mmol)溶于四氢呋喃(8mL)和水(0.5mL),于室温搅拌下加入硼氢化钠(0.2g,5.90mmol)。经过3h搅拌后,加入盐酸(3M,10mL)中止反应。混合物经蒸发、乙酸乙酯萃取及无水硫酸钠干燥后,蒸去溶剂并重结晶纯化得[6-(1-苯基-1-羟甲基)]-1,3-二氢-1-羟基-2,1-苯并氧杂硼。Dissolve (2-formyl-5-benzoyl)phenylboronic acid (0.8 g, 2.95 mmol) in tetrahydrofuran (8 mL) and water (0.5 mL), add sodium borohydride (0.2 g, 5.90 mmol) with stirring at room temperature ). After stirring for 3 h, hydrochloric acid (3M, 10 mL) was added to quench the reaction. After the mixture was evaporated, extracted with ethyl acetate and dried over anhydrous sodium sulfate, the solvent was evaporated and purified by recrystallization to obtain [6-(1-phenyl-1-hydroxymethyl)]-1,3-dihydro-1-hydroxyl -2,1-Benzoxaboron.

Figure BDA0002383090810000264
Figure BDA0002383090810000264

步骤H:化合物37的制备Step H: Preparation of Compound 37

取[6-(1-苯基-1-羟甲基)]-1,3-二氢-2,1-苯并氧杂硼-1-醇(0.2g,0.83mmol)溶于二氯甲烷(15mL),加入氯铬酸吡啶盐(0.5g,2.08mmol)和硅藻土(0.5g),将混合物在过滤前于室温下搅拌3h。产物经旋转蒸发仪蒸去溶剂后,重结晶得化合物37(0.15g,产率:76%)。熔点:137-139℃。1H NMR(400MHz,DMSO-d6)δ(ppm):9.35(s,1H),8.12(s,1H),7.87(dd,J=8.0,1.6Hz,1H),7.69(m,3H),7.57(m,3H),5.08(s,2H)。Dissolve [6-(1-phenyl-1-hydroxymethyl)]-1,3-dihydro-2,1-benzoxaborol-1-ol (0.2g, 0.83mmol) in dichloromethane (15 mL), pyridinium chlorochromate (0.5 g, 2.08 mmol) and diatomaceous earth (0.5 g) were added and the mixture was stirred at room temperature for 3 h before filtration. The product was evaporated to remove the solvent by a rotary evaporator, and then recrystallized to obtain compound 37 (0.15 g, yield: 76%). Melting point: 137-139°C. 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 9.35 (s, 1H), 8.12 (s, 1H), 7.87 (dd, J=8.0, 1.6 Hz, 1H), 7.69 (m, 3H) , 7.57 (m, 3H), 5.08 (s, 2H).

Figure BDA0002383090810000271
Figure BDA0002383090810000271

化合物38、39的合成均可参照实施例7化合物37的制备方法得到。The synthesis of compounds 38 and 39 can be obtained by referring to the preparation method of compound 37 in Example 7.

实施例8化合物40的制备Example 8 Preparation of Compound 40

取6-氨基-1,3-二氢-2,1-苯并氧杂硼-1-醇(500mg,3.36mmol)溶于乙腈(25mL),加入碳酸氢钠(845mg,10.1mmol)和苯甲酰氯(859μL,7.38mmol)。混合物在室温下搅拌2h,再用水中止反应,继续搅拌30min。混合物用乙酸乙酯萃取并用饱和碳酸氢钠、饱和氯化钠洗涤,最后以无水硫酸钠干燥。真空下浓缩沉淀产物,经过滤和干燥后得化合物40(310mg,产率:36%),熔点:186-193℃。1H NMR(300MHz,CDCl3)δ(ppm):8.82(s,1H),8.0-7.60(m,4H),7.52-7.32(m,3H),7.25(dd,J=7.8Hz,1H),5.00(s,2H)。Dissolve 6-amino-1,3-dihydro-2,1-benzoxaborol-1-ol (500mg, 3.36mmol) in acetonitrile (25mL), add sodium bicarbonate (845mg, 10.1mmol) and benzene Formyl chloride (859 μL, 7.38 mmol). The mixture was stirred at room temperature for 2 h, then quenched with water, and stirring was continued for 30 min. The mixture was extracted with ethyl acetate and washed with saturated sodium bicarbonate, saturated sodium chloride, and finally dried over anhydrous sodium sulfate. The precipitated product was concentrated under vacuum, filtered and dried to give compound 40 (310 mg, yield: 36%), m.p.: 186-193°C. 1 H NMR (300 MHz, CDCl 3 ) δ (ppm): 8.82 (s, 1H), 8.0-7.60 (m, 4H), 7.52-7.32 (m, 3H), 7.25 (dd, J=7.8Hz, 1H) , 5.00 (s, 2H).

Figure BDA0002383090810000272
Figure BDA0002383090810000272

化合物41、42的合成均可参照实施例8化合物40的制备方法得到。The synthesis of compounds 41 and 42 can be obtained by referring to the preparation method of compound 40 in Example 8.

实施例9化合物43的制备Example 9 Preparation of Compound 43

取6-氨基-1,3-二氢-2,1-苯并氧杂硼-1-醇(750mg,5.0mmol)溶于乙腈(25mL)中,加入碳酸钾(1.7g,12.6mmol)和苯磺酰氯(710μL,5.5mmol)。混合物在室温下搅拌2h,再用水中止反应,继续搅拌30min。混合物用乙酸乙酯萃取并用饱和氯化钠洗涤,以无水硫酸钠干燥。真空下浓缩沉淀产物,经过滤和干燥后得棕黄色固状化合物43(565.0mg,产率:39%),熔点:175-184℃。1H NMR(300MHz,CDCl3)δ(ppm):7.68(d,J=7.8Hz,2H),7.44(d,J=6.9Hz,1H),7.40-7.17(m,4H),7.13(d,J=7.8Hz,1H),4.94(s,2H)。Dissolve 6-amino-1,3-dihydro-2,1-benzoxaborol-1-ol (750mg, 5.0mmol) in acetonitrile (25mL), add potassium carbonate (1.7g, 12.6mmol) and Benzenesulfonyl chloride (710 μL, 5.5 mmol). The mixture was stirred at room temperature for 2 h, then quenched with water, and stirring was continued for 30 min. The mixture was extracted with ethyl acetate and washed with saturated sodium chloride, and dried over anhydrous sodium sulfate. The precipitated product was concentrated under vacuum, filtered and dried to give compound 43 (565.0 mg, yield: 39%) as a tan solid, melting point: 175-184°C. 1 H NMR (300 MHz, CDCl 3 ) δ (ppm): 7.68 (d, J=7.8 Hz, 2H), 7.44 (d, J=6.9 Hz, 1 H), 7.40-7.17 (m, 4H), 7.13 (d , J=7.8Hz, 1H), 4.94 (s, 2H).

Figure BDA0002383090810000281
Figure BDA0002383090810000281

化合物44、45的合成均可参照实施例9化合物43的制备方法得到。The synthesis of compounds 44 and 45 can be obtained by referring to the preparation method of compound 43 in Example 9.

实施例10化合物46的制备Example 10 Preparation of Compound 46

化合物46的制备方法,包括以下步骤:The preparation method of compound 46, comprises the following steps:

步骤A:4-苯氨基-2-溴甲苯的制备Step A: Preparation of 4-phenylamino-2-bromotoluene

取碘化苯(4.4g,21,56mmol)、4-甲基-3-溴苯胺(4.0g,21,56mmol)和二甲亚砜(50mL)混合,在氮气保护下依次加入碘化亚铜(0.8g,4.31mmol),L-脯氨酸(1.0g,8.61mmol)和叔丁氧基钠(4.1g,43.13mmol)。反应体系于50℃搅拌48h,加入冰(100.0g)并用乙酸乙酯萃取,以无水硫酸钠干燥。产物经旋蒸、硅胶柱层析纯化后得4-苯氨基-2-溴甲苯。Mix benzene iodide (4.4g, 21,56mmol), 4-methyl-3-bromoaniline (4.0g, 21,56mmol) and dimethyl sulfoxide (50mL), and add cuprous iodide successively under nitrogen protection (0.8 g, 4.31 mmol), L-proline (1.0 g, 8.61 mmol) and sodium tert-butoxide (4.1 g, 43.13 mmol). The reaction system was stirred at 50° C. for 48 h, ice (100.0 g) was added, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. The product was purified by rotary evaporation and silica gel column chromatography to obtain 4-phenylamino-2-bromotoluene.

Figure BDA0002383090810000282
Figure BDA0002383090810000282

步骤B:N-(4-甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯的制备Step B: Preparation of tert-butyl N-(4-methyl-3-bromophenyl)-N-phenylcarbamate

取4-苯氨基-2-溴甲苯(3.2g,12.44mmol)溶于四氢呋喃(60mL),于-80℃在30min内滴加六甲基二硅基胺基锂(27.4mL,27.4mmol),继续搅拌30min,在10min内滴加二碳酸二叔丁酯(6.0g,27.4mmol),在室温下反应14h。混合物蒸发得粗产品,经硅胶柱层析后得N-(4-甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯。Dissolve 4-phenylamino-2-bromotoluene (3.2 g, 12.44 mmol) in tetrahydrofuran (60 mL), and add lithium hexamethyldisilazide (27.4 mL, 27.4 mmol) dropwise at -80°C within 30 min, Stirring was continued for 30 min, and di-tert-butyl dicarbonate (6.0 g, 27.4 mmol) was added dropwise within 10 min, and the reaction was carried out at room temperature for 14 h. The mixture was evaporated to give a crude product which was subjected to silica gel column chromatography to give tert-butyl N-(4-methyl-3-bromophenyl)-N-phenylcarbamate.

Figure BDA0002383090810000283
Figure BDA0002383090810000283

步骤C:N-(4-羟甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯的制备Step C: Preparation of tert-butyl N-(4-hydroxymethyl-3-bromophenyl)-N-phenylcarbamate

取N-(4-甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯(4.3g,11.88mmol)溶于四氯甲烷(300mL),加入溴代丁二酰亚胺(2.5g,14.25mmol)和过氧化苯甲酰(0.3g,1.19mmol),回流20h。混合物冷却至室温并过滤,滤液真空下蒸发得粗产品,再经硅胶柱层析得中间产物N-(3-溴-4-溴甲基苯基)-N-苯基氨基甲酸叔丁基酯。取该中间产物(2.65g,6.0mmol)溶于N,N-二甲基甲酰胺(50mL),加入醋酸钠(2.5g,30mmol),于70℃搅拌5h。向混合物加入冰(100.0g)并用乙酸乙酯萃取、无水硫酸钠干燥,蒸去溶剂得乙酸中间体。取乙酸中间体(2.5g,5.95mmol)溶于甲醇(50mL),加入氢氧化钠水溶液(8%,15ml),回流1h。混合物用乙酸乙酯萃取,用水、饱和氯化钠洗涤,再以无水硫酸钠干燥,蒸去溶剂得N-(4-羟甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯。Dissolve tert-butyl N-(4-methyl-3-bromophenyl)-N-phenylcarbamate (4.3 g, 11.88 mmol) in tetrachloromethane (300 mL), add bromosuccinimide ( 2.5 g, 14.25 mmol) and benzoyl peroxide (0.3 g, 1.19 mmol), refluxed for 20 h. The mixture was cooled to room temperature and filtered. The filtrate was evaporated under vacuum to obtain the crude product, which was then subjected to silica gel column chromatography to obtain the intermediate product N-(3-bromo-4-bromomethylphenyl)-N-phenylcarbamate tert-butyl ester . The intermediate product (2.65 g, 6.0 mmol) was dissolved in N,N-dimethylformamide (50 mL), sodium acetate (2.5 g, 30 mmol) was added, and the mixture was stirred at 70° C. for 5 h. Ice (100.0 g) was added to the mixture, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and the solvent was evaporated to obtain an acetic acid intermediate. The acetic acid intermediate (2.5 g, 5.95 mmol) was dissolved in methanol (50 mL), sodium hydroxide aqueous solution (8%, 15 ml) was added, and the mixture was refluxed for 1 h. The mixture was extracted with ethyl acetate, washed with water and saturated sodium chloride, dried over anhydrous sodium sulfate, and the solvent was evaporated to obtain tertiary N-(4-hydroxymethyl-3-bromophenyl)-N-phenylcarbamate Butyl ester.

Figure BDA0002383090810000291
Figure BDA0002383090810000291

步骤D:N-(4-(四氢吡喃-2-氧基甲基)-3-溴苯基)-N-苯基氨基甲酸叔丁酯的制备Step D: Preparation of tert-butyl N-(4-(tetrahydropyran-2-oxymethyl)-3-bromophenyl)-N-phenylcarbamate

取N-(4-羟甲基-3-溴苯基)-N-苯基氨基甲酸叔丁酯(2.1g,5.55mmol)溶于二氯甲烷(50mL),依次加入3,4-二氢吡喃(0.9g,11.11mmol)、吡啶(28mg,0.35mmol)和一水合对甲苯磺酸(53mg,0.28mmol),于室温下反应48h。混合物经水、饱和氯化钠洗涤,再以无水硫酸钠干燥。产物蒸去溶剂后,经硅胶柱层析纯化得N-(4-(四氢吡喃-2-氧基甲基)-3-溴苯基)-N-苯基氨基甲酸叔丁酯。Dissolve N-(4-hydroxymethyl-3-bromophenyl)-N-phenylcarbamate tert-butyl ester (2.1 g, 5.55 mmol) in dichloromethane (50 mL), add 3,4-dihydrogen Pyran (0.9 g, 11.11 mmol), pyridine (28 mg, 0.35 mmol) and p-toluenesulfonic acid monohydrate (53 mg, 0.28 mmol) were reacted at room temperature for 48 h. The mixture was washed with water, saturated sodium chloride, and dried over anhydrous sodium sulfate. After the product was evaporated to remove the solvent, it was purified by silica gel column chromatography to obtain tert-butyl N-(4-(tetrahydropyran-2-oxymethyl)-3-bromophenyl)-N-phenylcarbamate.

Figure BDA0002383090810000292
Figure BDA0002383090810000292

步骤E:6-(N-叔丁氧羰基-N-苯基氨基)-1,3-二氢-2,1-苯并氧杂硼-1-醇的制备Step E: Preparation of 6-(N-tert-butoxycarbonyl-N-phenylamino)-1,3-dihydro-2,1-benzoxaborol-1-ol

取N-(4-(四氢吡喃-2-氧基甲基)-3-溴苯基)-N-苯基氨基甲酸叔丁酯(2.6g,5.54mmol)溶于无水四氢呋喃中,在氮气保护下在20min内于-80℃滴加正丁基锂(1.6M溶于己烷,3.98mL),继续搅拌20min,在10min内加入硼酸三异丙酯(1.47mL,6.37mmol)。混合物逐渐恢复到室温后,过夜搅拌。加入盐酸(6M,10mL)并搅拌1h,蒸去四氢呋喃,残留物用乙酸乙酯萃取,用水和饱和氯化钠洗涤,再以无水硫酸钠干燥,最后经硅胶柱层析纯化得硼酸中间产物,取该中间产物(0.6g,1.50mmol)溶于乙醇(20mL)中,加入吡啶(35.0mg,0.45mmol)和一水合对甲苯磺酸(85.0mg,0.45mmol),于50℃下反应4h,蒸去溶剂,将残留物溶于乙酸乙酯(50mL)并用水和饱和氯化钠洗涤,最后以无水硫酸钠干燥。粗产品经硅胶柱层析纯化得6-(N-叔丁氧羰基-N-苯基氨基)-1,3-二氢-2,1-苯并氧杂硼-1-醇。Dissolve N-(4-(tetrahydropyran-2-oxymethyl)-3-bromophenyl)-N-phenylcarbamate tert-butyl ester (2.6 g, 5.54 mmol) in anhydrous tetrahydrofuran, Under nitrogen protection, n-butyllithium (1.6M in hexane, 3.98 mL) was added dropwise at -80°C within 20 min, stirring was continued for 20 min, and triisopropyl borate (1.47 mL, 6.37 mmol) was added within 10 min. After the mixture gradually returned to room temperature, it was stirred overnight. Hydrochloric acid (6M, 10 mL) was added and stirred for 1 h, tetrahydrofuran was evaporated, the residue was extracted with ethyl acetate, washed with water and saturated sodium chloride, dried over anhydrous sodium sulfate, and finally purified by silica gel column chromatography to obtain the intermediate product of boric acid , take the intermediate product (0.6 g, 1.50 mmol) and dissolve it in ethanol (20 mL), add pyridine (35.0 mg, 0.45 mmol) and p-toluenesulfonic acid monohydrate (85.0 mg, 0.45 mmol), and react at 50 ° C for 4 h , the solvent was evaporated, the residue was dissolved in ethyl acetate (50 mL) and washed with water and saturated sodium chloride, and finally dried over anhydrous sodium sulfate. The crude product was purified by silica gel column chromatography to obtain 6-(N-tert-butoxycarbonyl-N-phenylamino)-1,3-dihydro-2,1-benzoxaborol-1-ol.

Figure BDA0002383090810000293
Figure BDA0002383090810000293

步骤F:化合物46的制备Step F: Preparation of Compound 46

取6-(N-叔丁氧羰基-N-苯基氨基)-1,3-二氢-2,1-苯并氧杂硼-1-醇(150.0mg,0.46mmol)溶于二氯甲烷(10mL),在氮气保护下于0℃滴加三氟乙酸(0.4mL,5.38mmol),待混合物缓慢恢复至室温并搅拌3h,加入饱和碳酸氢钠中和反应体系。分离有机层,以饱和氯化钠洗涤、无水硫酸钠干燥,蒸去溶剂并以硅胶柱层析和重结晶纯化得化合物46(13.2mg,产率:13%),熔点:108-110℃。1H NMR(300MHz,DMSO-d6)δ(ppm):9.07(s,1H),8.12(s,1H),7.50(s,1H),7.22(m,4H),7.05(d,J=8.1Hz,2H),6.80(d,J=7.2Hz,1H),4.91(s,2H)。Dissolve 6-(N-tert-butoxycarbonyl-N-phenylamino)-1,3-dihydro-2,1-benzoxaborol-1-ol (150.0 mg, 0.46 mmol) in dichloromethane (10 mL), trifluoroacetic acid (0.4 mL, 5.38 mmol) was added dropwise at 0°C under nitrogen protection, the mixture was slowly returned to room temperature and stirred for 3 h, saturated sodium bicarbonate was added to neutralize the reaction system. The organic layer was separated, washed with saturated sodium chloride, dried over anhydrous sodium sulfate, evaporated to remove the solvent and purified by silica gel column chromatography and recrystallization to obtain compound 46 (13.2 mg, yield: 13%), melting point: 108-110°C . 1 H NMR (300MHz, DMSO-d 6 )δ(ppm): 9.07(s, 1H), 8.12(s, 1H), 7.50(s, 1H), 7.22(m, 4H), 7.05(d, J= 8.1Hz, 2H), 6.80 (d, J=7.2Hz, 1H), 4.91 (s, 2H).

Figure BDA0002383090810000301
Figure BDA0002383090810000301

化合物47、48的合成均可参照实施例10化合物46的制备方法得到。The synthesis of compounds 47 and 48 can be obtained by referring to the preparation method of compound 46 in Example 10.

实施例11化合物49的制备Example 11 Preparation of Compound 49

化合物49的制备方法,包括以下步骤:The preparation method of compound 49, comprises the following steps:

步骤A:4-苄基-2-甲氧基苯甲醛的制备Step A: Preparation of 4-benzyl-2-methoxybenzaldehyde

取苄基硼酸(2.15g,10mmol)、2-甲氧基-4-溴苯甲醛(2.44g,18mmol)、[1,1'-双(二苯基膦基)二茂铁]二氯化钯(1.46g,2mmol)、氟化铯(3.02g,20mmol)和碳酸钾(4.14g,30mmol)溶于二氧六环(30mL),排除空气10min并于80℃加热16h,冷却至室温后,用乙酸乙酯稀释,最后以硅藻土过滤浓缩。粗产品经硅胶柱层析后得4-苄基-2-甲氧基苯甲醛。Take benzylboronic acid (2.15g, 10mmol), 2-methoxy-4-bromobenzaldehyde (2.44g, 18mmol), [1,1'-bis(diphenylphosphino)ferrocene]dichloride Palladium (1.46g, 2mmol), cesium fluoride (3.02g, 20mmol) and potassium carbonate (4.14g, 30mmol) were dissolved in dioxane (30mL), the air was removed for 10min and heated at 80°C for 16h, cooled to room temperature , diluted with ethyl acetate, and finally concentrated by filtration through celite. The crude product was subjected to silica gel column chromatography to obtain 4-benzyl-2-methoxybenzaldehyde.

Figure BDA0002383090810000302
Figure BDA0002383090810000302

步骤B:4-苄基-2-羟基苯甲醛的制备Step B: Preparation of 4-benzyl-2-hydroxybenzaldehyde

取4-苄基-2-甲氧基苯甲醛(1.14g,5mmol)、三氯化铈(1.85g,7.5mmol)和碘化钠(1.13g,7.5mmol)溶于氰化甲烷(20mL),回流18h,用乙酸乙酯稀释并用无水硫代硫酸钠洗涤,干燥后浓缩得4-苄基-2-羟基苯甲醛。Dissolve 4-benzyl-2-methoxybenzaldehyde (1.14g, 5mmol), cerium trichloride (1.85g, 7.5mmol) and sodium iodide (1.13g, 7.5mmol) in cyanide methane (20mL) , refluxed for 18h, diluted with ethyl acetate and washed with anhydrous sodium thiosulfate, dried and concentrated to obtain 4-benzyl-2-hydroxybenzaldehyde.

Figure BDA0002383090810000303
Figure BDA0002383090810000303

步骤C:4-苄基-2-三氟甲磺酸基苯甲醛的制备Step C: Preparation of 4-benzyl-2-trifluoromethanesulfonylbenzaldehyde

取4-苄基-2-羟基苯甲醛(0.44g,2.08mmol)溶于二氯甲烷(10mL),溶液冷却至-78℃,加入三乙胺(0.68mL,6.24mmol)和三氟甲磺酸酐(0.40mL,3.12mmol)。混合物在-78℃下搅拌30min,用水(2mL)中止反应、二氯甲烷(50mL)稀释及盐酸(1M,20mL)洗涤,干燥后浓缩得4-苄基-2-三氟甲磺酸基苯甲醛。Dissolve 4-benzyl-2-hydroxybenzaldehyde (0.44g, 2.08mmol) in dichloromethane (10mL), cool the solution to -78°C, add triethylamine (0.68mL, 6.24mmol) and trifluoromethanesulfonic acid Anhydride (0.40 mL, 3.12 mmol). The mixture was stirred at -78°C for 30 min, quenched with water (2 mL), diluted with dichloromethane (50 mL) and washed with hydrochloric acid (1 M, 20 mL), dried and concentrated to give 4-benzyl-2-trifluoromethanesulfonic acid benzene formaldehyde.

Figure BDA0002383090810000311
Figure BDA0002383090810000311

步骤D:4-苄基-2-(4,4,5,5-四甲基-[1,3,2]二氧代硼戊烷-2-基苯甲醛的制备Step D: Preparation of 4-benzyl-2-(4,4,5,5-tetramethyl-[1,3,2]dioxoboropentan-2-ylbenzaldehyde

取4-苄基-2-三氟甲磺酸基苯甲醛(0.68g,2.08mmol)、双联频哪醇基二硼(0.80g,3.12mmol)、[1,1'-双(二苯基膦基)二茂铁]二氯化钯(0.31g,0.42mmol)和醋酸钾(0.61g,6.24mmol)溶于二氧六环(15mL),在80℃下反应16h后冷却至室温,再用乙酸乙酯稀释,以硅藻土为介质过滤浓缩,粗产品经柱层析纯化后得4-苄基-2-(4,4,5,5-四甲基-[1,3,2]二氧代硼戊烷-2-基苯甲醛。Take 4-benzyl-2-trifluoromethanesulfonic acid benzaldehyde (0.68g, 2.08mmol), double pinacol diboron (0.80g, 3.12mmol), [1,1'-bis(diphenylene) (0.31 g, 0.42 mmol) and potassium acetate (0.61 g, 6.24 mmol) were dissolved in dioxane (15 mL), reacted at 80 °C for 16 h and cooled to room temperature, Diluted with ethyl acetate, filtered and concentrated with celite as medium, the crude product was purified by column chromatography to obtain 4-benzyl-2-(4,4,5,5-tetramethyl-[1,3, 2] Dioxaboropent-2-ylbenzaldehyde.

Figure BDA0002383090810000312
Figure BDA0002383090810000312

步骤E:化合物49的制备Step E: Preparation of Compound 49

取4-苄基-2-(4,4,5,5-四甲基-[1,3,2]二氧代硼戊烷-2-基苯甲醛(0.61g,1.89mmol)溶于甲醇(10mL)和四氢呋喃(10mL)中,分批加入硼氢化钠(0.16g,4.17mmol)。混合物于0℃搅拌30min,用盐酸(6M,0.5mL)中止反应并以水(20mL)稀释,继续在室温下搅拌1h。收集固体产物并用水(10mL)洗涤,真空下干燥得化合物49(290mg,产率:68%),熔点:173-175℃。1H NMR(300MHz,CDCl3)δ(ppm):7.56(s,1H),7.35-7.22(m,4H),7.22-7.13(m,3H),5.06(s,2H),4.01(s,2H)。Dissolve 4-benzyl-2-(4,4,5,5-tetramethyl-[1,3,2]dioxoboropentan-2-ylbenzaldehyde (0.61g, 1.89mmol) in methanol (10 mL) and tetrahydrofuran (10 mL), sodium borohydride (0.16 g, 4.17 mmol) was added in portions. The mixture was stirred at 0 °C for 30 min, quenched with hydrochloric acid (6 M, 0.5 mL) and diluted with water (20 mL), continued It was stirred at room temperature for 1 h. The solid product was collected and washed with water (10 mL) and dried under vacuum to give compound 49 (290 mg, yield: 68%), melting point: 173-175°C. 1 H NMR (300 MHz, CDCl 3 ) δ ( ppm): 7.56 (s, 1H), 7.35-7.22 (m, 4H), 7.22-7.13 (m, 3H), 5.06 (s, 2H), 4.01 (s, 2H).

Figure BDA0002383090810000313
Figure BDA0002383090810000313

化合物50、51的合成均可参照实施例11化合物49的制备方法得到。The synthesis of compounds 50 and 51 can be obtained by referring to the preparation method of compound 49 in Example 11.

实验例:生物活性测试实例Experimental example: biological activity test example

本发明化合物的杀菌活性测试方法如下:The bactericidal activity test method of the compound of the present invention is as follows:

采用生长速率法对常见的6种农业真菌草莓灰霉病菌、番茄早疫病菌、小麦赤霉病菌、水稻纹枯病菌、黄瓜炭疽病菌、苹果斑点病菌进行了初步抑菌活性测定,并对其中部分抑制率较高的化合物进行EC50毒力测定。The growth rate method was used to determine the preliminary antibacterial activities of 6 common agricultural fungi, Strawberry Botrytis cinerea, Tomato early phytophthora, Wheat scab, Rhizoctonia oryzae, Cucumber Anthracnose, and Apple Spot. Some compounds with higher inhibition rates were subjected to EC 50 virulence assays.

具体操作为:测试用的6种真菌在抑菌测试之前需在PDA培养基上活化一次,并在25℃下培养2-8天,菌丝边缘用直径5mm打孔器打孔以做备用。称取苯并氧杂硼类-1-醇类化合物并以N,N-二甲基甲酰胺为溶剂,配制成相应浓度的供试液,一般浓度为ppm级别。向培养基中取配制好的供试液、硫酸链霉素,并以无供试品的N,N-二甲基甲酰胺溶液作为对照品,将6种真菌分别接种至相应的已灭菌的培养基中,然后置于25℃培养箱培养。培养期间观察真菌的生长情况,测定真菌在不同供试品存在下的生长情况。The specific operations are as follows: the 6 kinds of fungi used in the test need to be activated once on the PDA medium before the antibacterial test, and cultured at 25°C for 2-8 days. Weigh the benzoxaborol-1-alcohol compounds and use N,N-dimethylformamide as the solvent to prepare the test solution of the corresponding concentration, the general concentration is ppm level. Take the prepared test solution and streptomycin sulfate from the culture medium, and use the N,N-dimethylformamide solution without the test substance as the reference substance, inoculate the 6 kinds of fungi into the corresponding sterilized medium, and then placed in a 25°C incubator. The growth of fungi was observed during the culture period, and the growth of fungi in the presence of different test substances was determined.

生物活性测试所用6种真菌的名称及简称见表4The names and abbreviations of the 6 fungi used in the biological activity test are shown in Table 4

表4Table 4

普通名common name 拉丁名Latin name 本文简称this article for short 草莓灰霉病菌Strawberry Botrytis cinerea Botrytis cinreaBotrytis cinrea A菌A bacteria 番茄早疫病菌tomato early blight Alternaria solaniAlternaria solani C菌C bacteria 小麦赤霉病菌Fusarium head blight Gibberella zeaeGibberella zeae D菌D bacteria 水稻纹枯病菌Rice sheath blight Rhizoctonia solaniRhizoctonia solani E菌E bacteria 黄瓜炭疽病菌Cucumber anthracnose Cucumber anthraxCucumber anthrax G菌G bacteria 苹果斑点病菌Apple Spot Alternaria Leaf SpotAlternaria Leaf Spot H菌H bacteria

实施例中部分化合物初筛测试结果及EC50毒力测定结果见表5和表6(真菌名称以简称代表,表6中的蛇床子素、啶酰菌胺和多菌灵为已上市的杀菌剂对照)In the embodiment, the preliminary screening test results of some compounds and the EC 50 toxicity assay results are shown in Table 5 and Table 6 (the fungal name is represented by abbreviation, and the osthole, boscalid and carbendazim in table 6 are listed sterilizations. agent control)

表5table 5

Figure BDA0002383090810000321
Figure BDA0002383090810000321

Figure BDA0002383090810000331
Figure BDA0002383090810000331

Figure BDA0002383090810000341
Figure BDA0002383090810000341

Figure BDA0002383090810000351
Figure BDA0002383090810000351

表6Table 6

Figure BDA0002383090810000352
Figure BDA0002383090810000352

Figure BDA0002383090810000361
Figure BDA0002383090810000361

从表5和表6所示的结果可以看出上述化合物均表现很好的杀菌效果,在低浓度时均可以对农作物真菌表现出抑制活性。对于某些菌类,这些化合物甚至比蛇床子素、啶酰菌胺和多菌灵的抑菌效果要好,具有杀菌广谱性。From the results shown in Table 5 and Table 6, it can be seen that the above compounds all exhibit good bactericidal effects, and can exhibit inhibitory activity against crop fungi at low concentrations. For some fungi, these compounds are even better than osthole, boscalid and carbendazim, and have broad-spectrum bactericidal properties.

综上所述,本发明所述的苯并氧杂硼-1-醇类化合物具有杀灭农作物病菌的作用,作为一种亮氨酰-tRNA合成酶抑制剂,利用原核和真核生物的进化差异,该类物质有较高的选择性、安全性,是一类潜在的广谱、安全、高效的杀菌物质。To sum up, the benzoxaborol-1-ol compound of the present invention has the effect of killing crop pathogens, and as a leucyl-tRNA synthetase inhibitor, it utilizes the evolution of prokaryotic and eukaryotic organisms. This kind of substance has high selectivity and safety, and is a kind of potential broad-spectrum, safe and efficient bactericidal substance.

以上详细描述了本发明的涉及的化合物及其用途。但是,本发明并不限于上述实施方式中的具体细节,在本发明的技术构思范围内,可以对本发明的技术方案进行多种简单变型,这些简单变型均属于本发明的保护范围。The compounds involved in the present invention and their uses are described in detail above. However, the present invention is not limited to the specific details of the above-mentioned embodiments, and within the scope of the technical concept of the present invention, various simple modifications can be made to the technical solutions of the present invention, and these simple modifications all belong to the protection scope of the present invention.

另外需要说明的是,在上述具体实施方式中所描述的各个具体技术特征,在不矛盾的情况下,可以通过任何合适的方式进行组合,为了避免不必要的重复,本发明对各种可能的组合方式不再另行说明。In addition, it should be noted that the specific technical features described in the above-mentioned specific embodiments can be combined in any suitable manner under the condition of no contradiction. In order to avoid unnecessary repetition, the present invention has The combination method will not be specified otherwise.

此外,本发明的各种不同的实施方式之间也可以进行任意组合,只要其不违背本发明的思想,其同样应当视为本发明所公开的内容。In addition, the various embodiments of the present invention can also be combined arbitrarily, as long as they do not violate the spirit of the present invention, they should also be regarded as the contents disclosed in the present invention.

Claims (7)

1.苯并氧杂硼类-1-醇类化合物,其特征在于,该类化合物具有如下结构式:1. benzoxaboron-1-alcohol compounds, characterized in that, the compounds have the following structural formula:
Figure FDA0002383090800000011
Figure FDA0002383090800000011
其中,R与4、5、6或7位C相连,R为-R1或-L-R3,R’为-CH2-或-Y-CH2-;Wherein, R is connected to C at 4, 5, 6 or 7, R is -R 1 or -LR 3 , and R' is -CH 2 - or -Y-CH 2 -; 其中,R1选自氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基、C2-C8醛基卤代炔基、碳芳基、杂环基、氰基、硝基以及其他基团中的一种;wherein, R 1 is selected from hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkyne group, C 2 -C 8 haloalkynyl, C 1 -C 8 hydroxyalkyl, C 1 -C 8 hydroxy haloalkyl, C 2 -C 8 hydroxy alkenyl, C 2 -C 8 hydroxy haloalkenyl, C 2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 - C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 -mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl , C 1 -C 8 alkylthio, C 1 -C 8 Haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldehyde Alkyl alkyl, C 1 -C 8 aldohaloalkyl, C 2 -C 8 aldoalkenyl, C 2 -C 8 aldohaloalkenyl, C 2 -C 8 aldoalkynyl, C 2 -C 8. One of aldehyde haloalkynyl, carboaryl, heterocyclic, cyano, nitro and other groups; 所述其他基团为被1或多个独立选自以下基团取代的氨基、羰基、硫代羰基、磺酰基、羰基氨基、磺酰基氨基、硫代羰基氨基、氨基羰基、氨基磺酰基或氨基硫代羰基:氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、氰基和硝基;The other groups are amino, carbonyl, thiocarbonyl, sulfonyl, carbonylamino, sulfonylamino, thiocarbonylamino, aminocarbonyl, aminosulfonyl, or amino substituted with one or more groups independently selected from Thiocarbonyl: hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C2 - C8haloalkynyl , C1 - C8hydroxyalkyl , C1 - C8hydroxyhaloalkyl , C2- C8hydroxyalkenyl , C2 - C8hydroxyhaloalkenyl , C2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkene Oxy group, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 alkylthio, C 1 -C 8 haloalkylthio base, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, cyano and nitro; 其中,L选自-O-、-S-、-CHR4-、-NR5-、-COO-、硫代羰基、磺酰基、羰基氨基、磺酰基氨基、硫代羰基氨基、氨基羰基、氨基磺酰基或氨基硫代羰基,R4、R5分别独立选自氢、卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基或C2-C8醛基卤代炔基;Wherein, L is selected from -O-, -S-, -CHR 4 -, -NR 5 -, -COO-, thiocarbonyl, sulfonyl, carbonylamino, sulfonylamino, thiocarbonylamino, aminocarbonyl, amino Sulfonyl or aminothiocarbonyl, R 4 and R 5 are independently selected from hydrogen, halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 Haloalkenyl, C2- C8alkynyl , C2 - C8haloalkynyl , C1 - C8hydroxyalkyl , C1 - C8hydroxyhaloalkyl , C2- C8hydroxyalkenyl , C 2 -C 8 hydroxyhaloalkenyl, C 2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl , C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 - C 8 alkylthio, C 1 -C 8 haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 halogen Alkynylthio, C 1 -C 8 aldehyde alkyl, C 1 -C 8 aldehyde haloalkyl, C 2 -C 8 aldehyde alkenyl, C 2 -C 8 aldehyde haloalkenyl, C 2 - C 8 aldehyde alkynyl or C 2 -C 8 aldehyde haloalkynyl; 其中,R3为碳芳基或杂环基;Wherein, R 3 is carboaryl or heterocyclyl; 其中,Y与苯环相连,选自-O-、-S-、-CH2-、未取代或被1个独立选自以下基团取代的氨基:卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基、C2-C8醛基卤代炔基、碳芳基或杂环基。Wherein, Y is connected to the benzene ring, selected from -O-, -S-, -CH 2 -, unsubstituted or amino substituted by 1 group independently selected from the following groups: halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, C 1 -C 8 hydroxyalkane group, C 1 -C 8 hydroxyhaloalkyl, C 2 -C 8 hydroxy alkenyl, C 2 -C 8 hydroxy haloalkenyl, C 2 -C 8 hydroxy alkynyl, C 2 -C 8 hydroxy haloalkynyl , C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercaptoalkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 - C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 -C 8 alkylthio, C 1 -C 8 haloalkylthio, C 2 -C 8 alkenylthio, C 2 -C 8 halogen Alkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldehyde alkyl, C 1 -C 8 aldehyde haloalkyl, C 2 -C 8 Aldoalkenyl, C2 - C8aldohaloalkenyl , C2 - C8aldoalkynyl , C2 - C8aldohaloalkynyl , carboaryl or heterocyclyl.
2.根据权利要求1所述的苯并氧杂硼类-1-醇类化合物,其特征在于,所述苯并氧杂硼类-1-醇类化合物结构式如式(I)~(III)中任一所示的结构:2 . The benzoxaborol-1-alcohol compound according to claim 1 , wherein the structural formula of the benzoxaborol-1-alcohol compound is as formula (I) to (III) The structure shown in either:
Figure FDA0002383090800000021
Figure FDA0002383090800000021
3.根据权利要求1所述的苯并氧杂硼类-1-醇类化合物,其特征在于:所述R3选自未取代或被1~4个独立选自以下基团取代的碳芳基或杂环基:卤素、C1-C8烷基、C1-C8卤代烷基、C2-C8烯基、C2-C8卤代烯基、C2-C8炔基、C2-C8卤代炔基、C1-C8羟基烷基、C1-C8羟基卤代烷基、C2-C8羟基烯基、C2-C8羟基卤代烯基、C2-C8羟基炔基、C2-C8羟基卤代炔基、C1-C8烷氧基、C1-C8卤代烷氧基、C2-C8烯氧基、C2-C8卤代烯氧基、C2-C8炔氧基、C2-C8卤代炔氧基、C1-C8巯基烷基、C1-C8巯基卤代烷基、C2-C8巯基烯基、C2-C8巯基卤代烯基、C2-C8巯基炔基、C2-C8巯基卤代炔基、C1-C8烷硫基、C1-C8卤代烷硫基、C2-C8烯硫基、C2-C8卤代烯硫基、C2-C8炔硫基、C2-C8卤代炔硫基、C1-C8醛基烷基、C1-C8醛基卤代烷基、C2-C8醛基烯基、C2-C8醛基卤代烯基、C2-C8醛基炔基、C2-C8醛基卤代炔基;3. The benzoxaborol-1-alcohol compound according to claim 1, characterized in that: the R 3 is selected from unsubstituted or substituted by 1-4 groups independently selected from the following groups of carbon aromatics radical or heterocyclyl: halogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C2 - C8haloalkynyl , C1 - C8hydroxyalkyl , C1 - C8hydroxyhaloalkyl , C2- C8hydroxyalkenyl , C2 - C8hydroxyhaloalkenyl , C2 -C 8 hydroxyalkynyl, C 2 -C 8 hydroxyhaloalkynyl, C 1 -C 8 alkoxy, C 1 -C 8 haloalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 Haloalkenyloxy, C 2 -C 8 alkynyloxy, C 2 -C 8 haloalkynyloxy, C 1 -C 8 mercaptoalkyl, C 1 -C 8 mercaptohaloalkyl, C 2 -C 8 mercapto Alkenyl, C 2 -C 8 mercaptohaloalkenyl, C 2 -C 8 mercaptoalkynyl, C 2 -C 8 mercaptohaloalkynyl, C 1 -C 8 alkylthio, C 1 -C 8 halogenated alkylthio base, C 2 -C 8 alkenylthio, C 2 -C 8 haloalkenylthio, C 2 -C 8 alkynylthio, C 2 -C 8 haloalkynylthio, C 1 -C 8 aldol alkyl alkenyl, C 1 -C 8 aldol haloalkyl, C 2 -C 8 aldoalkenyl, C 2 -C 8 aldol haloalkenyl, C 2 -C 8 aldol alkynyl, C 2 -C 8 aldehyde haloalkynyl; 其中,杂环基选自氧硫杂环、吗啉、吡喃、吡啶、嘧啶、哒嗪、喹啉、吡唑、噻唑、异噻唑、噻二唑、噻吩、呋喃、噁唑、异噁唑、噁二唑,或这些杂环含卤素的衍生物。Wherein, the heterocyclic group is selected from the group consisting of oxthiane, morpholine, pyran, pyridine, pyrimidine, pyridazine, quinoline, pyrazole, thiazole, isothiazole, thiadiazole, thiophene, furan, oxazole, isoxazole , oxadiazoles, or these heterocyclic halogen-containing derivatives. 4.权利要求1~3任一项所述的苯并氧杂硼类-1-醇类化合物的制备方法,其特征在于,当R为-R1,R’为-CH2-时,所述苯并氧杂硼类-1-醇类化合物的制备方法如下:溴代苯甲醛或溴代苯甲酸类化合物或氰基取代的溴代甲苯类化合物与氯甲基甲醚反应,转换为羟基被甲氧基甲基保护的溴代苯甲醇类化合物,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,最后在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物;4. The preparation method of benzoxaborol-1-alcohol compounds according to any one of claims 1 to 3, wherein when R is -R 1 and R' is -CH 2 -, the The preparation method of the benzoxaborol-1-alcohol compounds is as follows: bromobenzaldehyde or bromobenzoic acid compounds or cyano-substituted bromotoluene compounds react with chloromethyl methyl ether to convert into hydroxyl groups The bromobenzyl alcohol compound protected by methoxymethyl group is then reacted with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature to connect the boron atom to the benzene ring, and finally deprotected in hydrochloric acid, spontaneously Ring into the corresponding benzoxaborol-1-ol compounds; 或当R为-R1,R’为-Y-CH2-时,所述苯并氧杂硼类-1-醇类化合物的制备方法如下:由溴代苯甲醛类化合物发生维蒂希反应经水解后得到溴代苯乙醛类化合物,再与氯甲基甲醚反应得到羟基被甲氧基甲基保护的溴代苯乙醇类化合物,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的六元苯并氧杂硼-1-醇类化合物。Or when R is -R 1 and R' is -Y-CH 2 -, the preparation method of the benzoxaborol-1-alcohol compounds is as follows: Wittig reaction occurs from bromobenzaldehyde compounds After hydrolysis, bromophenylacetaldehyde compounds are obtained, which are then reacted with chloromethyl methyl ether to obtain bromophenethyl alcohol compounds whose hydroxyl groups are protected by methoxymethyl groups. Finally, they are reacted with triisopropyl borate in n-butyllithium. The low temperature reaction in tetrahydrofuran solvent made the boron atom connected to the benzene ring, deprotected in hydrochloric acid, and spontaneously formed a ring to obtain the corresponding six-membered benzoxaborol-1-ol compounds. 5.权利要求1~3任一项所述的苯并氧杂硼类-1-醇类化合物的制备方法,其特征在于,当R为L-R3,R’为-CH2-,L为S或O时,由(硫)酚类化合物和2-溴-4-氟苯甲醛反应得到(硫)醚类化合物,再经硼氢化钠还原得III-12,然后III-12与氯甲基甲醚反应得III-13,最后再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的苯并氧杂硼-1-醇类化合物III-14;5. The preparation method of benzoxaborol-1-alcohol compounds according to any one of claims 1 to 3, wherein when R is LR 3 , R' is -CH 2 -, and L is S or O, by (thio) phenolic compound and 2-bromo-4-fluorobenzaldehyde reaction to obtain (thio) ether compound, then by sodium borohydride reduction to obtain III-12, then III-12 and chloromethyl methyl The ether reacts to obtain III-13, and finally reacts with triisopropyl borate in tetrahydrofuran solvent of n-butyllithium at low temperature so that the boron atom is connected to the benzene ring, deprotected in hydrochloric acid, and spontaneously forms a ring to obtain the corresponding benzoxy Boron-1-ol compounds III-14; 或当R为L-R3,R’为-CH2-,L为硫代羰基或磺酰基时,化合物III-14经高碘酸钠氧化分别得到相应的苯并氧杂硼-1-醇类化合物III-16和III-17;Or when R is LR 3 , R' is -CH 2 -, and L is thiocarbonyl or sulfonyl, compound III-14 is oxidized by sodium periodate to obtain the corresponding benzoxaborol-1-ols, respectively III-16 and III-17; 或当R为L-R3,R’为-CH2-,L为羰基时,取代苯或杂环类化合物III-18和III-19发生傅克反应得化合物III-20,然后经溴代丁二酰亚胺溴代、与醋酸钠在碱性条件下水解得化合物III-21氧化得化合物III-22,接着与乙二醇反应得化合物III-23,再与硼酸三异丙酯在正丁基锂的四氢呋喃溶剂中低温反应使硼原子连接在苯环上,在盐酸中脱保护,自发成环得到相应的化合物III-25,最后用沙瑞特试剂反应得苯并氧杂硼-1-醇类化合物III-26;Or when R is LR 3 , R' is -CH 2 -, and L is carbonyl, substituted benzene or heterocyclic compounds III-18 and III-19 undergo Friedel-Crafts reaction to obtain compound III-20, and then pass through bromobutanedi The imide is brominated, hydrolyzed with sodium acetate under alkaline conditions to obtain compound III-21 and oxidized to obtain compound III-22, then reacted with ethylene glycol to obtain compound III-23, and then reacted with triisopropyl borate in n-butyl The low temperature reaction of lithium in tetrahydrofuran solvent makes the boron atom connected to the benzene ring, deprotected in hydrochloric acid, and spontaneously formed into a ring to obtain the corresponding compound III-25, and finally reacted with Sarreth reagent to obtain benzoxaborol-1-ol Class compound III-26; 或当R为L-R3,R’为-CH2-,L为羰基氨基、硫代羰基氨基或磺酰基氨基时,化合物III-27与不同的酰氯、硫代酰氯、磺酰氯偶联形成由L连接的苯并氧杂硼-1-醇类化合物III-28、III-29、III-30;Or when R is LR 3 , R' is -CH 2 -, and L is carbonylamino, thiocarbonylamino or sulfonylamino, compound III-27 is coupled with different acid chlorides, thioacyl chlorides, and sulfonyl chlorides to form L Linked benzoxaborol-1-ols III-28, III-29, III-30; 或当R为L-R3,R’为-CH2-,L为NH时,由碘代化合物III-31和化合物III-32,在叔丁氧羰基保护下形成醇类化合物III-35,然后再与3,4-二氢吡喃在吡啶存在下,形成四氢吡喃保护的醇羟基,最后在酸性条件下脱保护并形成苯并氧杂硼-1-醇类化合物III-39;Or when R is LR 3 , R' is -CH 2 -, and L is NH, an alcohol compound III-35 is formed from the iodo compound III-31 and compound III-32 under the protection of tert-butoxycarbonyl, and then With 3,4-dihydropyran in the presence of pyridine, the alcohol hydroxyl group protected by tetrahydropyran is formed, and finally deprotected under acidic conditions to form benzoxaborol-1-ol compound III-39; 或当R为L-R3,R’为-CH2-,L为CH2时,硼酸类化合物III-40和2-甲氧基-4-溴苯甲醛发生Suzuki偶联反应得到III-42,再经三氟磺酸酐在三氯化铈和碘化钠作用下转化成三氟甲基磺酸盐III-44,经硼烷化后,最终在酸性条件下水解得相应的苯并氧杂硼-1-醇类化合物III-46。Or when R is LR 3 , R' is -CH 2 -, and L is CH 2 , boronic acid compound III-40 and 2-methoxy-4-bromobenzaldehyde undergo Suzuki coupling reaction to obtain III-42, and then The trifluorosulfonic anhydride was converted into trifluoromethanesulfonate III-44 under the action of cerium trichloride and sodium iodide, and after boraneation, the corresponding benzoxaboron- 1-Alcohols III-46. 6.权利要求1~3任一项所述的苯并氧杂硼类-1-醇类化合物在防治农作物病害领域中的应用。6. Application of the benzoxaborol-1-alcohol compound according to any one of claims 1 to 3 in the field of preventing and treating crop diseases. 7.根据权利要求6所述的应用,其特征在于,所述农作物病害为早疫病菌、赤霉病菌、纹枯病菌、灰霉病菌、腐霉病菌、斑点病菌、炭疽病菌、晚疫病菌和霜霉病菌中的一种或几种。7. application according to claim 6, is characterized in that, described crop disease is early blight, scab, sheath blight, botrytis cinerea, Pythium, speckle, anthracnose, late blight and one or more of downy mildew.
CN202010090057.0A 2019-02-21 2020-02-12 Benzoxaborol-1-ol compound and preparation method and application thereof Pending CN111233908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2019101351239 2019-02-21
CN201910135123 2019-02-21

Publications (1)

Publication Number Publication Date
CN111233908A true CN111233908A (en) 2020-06-05

Family

ID=70879872

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010090057.0A Pending CN111233908A (en) 2019-02-21 2020-02-12 Benzoxaborol-1-ol compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111233908A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11560393B2 (en) 2018-08-18 2023-01-24 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
CN116715692A (en) * 2023-06-20 2023-09-08 广西田园生化股份有限公司 Application of oxaborane compound in prevention and treatment of plant diseases
US11834466B2 (en) 2017-11-30 2023-12-05 5Metis, Inc. Benzoxaborole compounds and formulations thereof

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101505603A (en) * 2005-12-30 2009-08-12 安纳考尔医药公司 Boron-containing small molecules
US8669207B1 (en) * 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
CN103857289A (en) * 2011-10-07 2014-06-11 先正达参股股份有限公司 Method for protecting useful plants or plant propagation material
WO2014173880A1 (en) * 2013-04-22 2014-10-30 Syngenta Participations Ag Novel microbiocides
WO2015097276A1 (en) * 2013-12-23 2015-07-02 Syngenta Participations Ag Benzoxaborole fungicides
CN105101791A (en) * 2013-01-30 2015-11-25 美国陶氏益农公司 Use of phenylboronic acid half esters as volatile antimicrobial agents on meat, plants or plant parts
GB2531098A (en) * 2014-05-28 2016-04-13 Syngenta Participations Ag Novel microbiocides
CN106029673A (en) * 2014-02-17 2016-10-12 先正达参股股份有限公司 Microbiocidally active benzoxaboroles
WO2017029289A1 (en) * 2015-08-17 2017-02-23 Syngenta Participations Ag 1-hydroxy-3h-2,1-benzoxaborole derivatives and their use as microbiocides
CN107108661A (en) * 2015-01-13 2017-08-29 先正达参股股份有限公司 Kill the benzoxaborole heterocyclic pentene of microorganism
WO2017216191A1 (en) * 2016-06-13 2017-12-21 Syngenta Participations Ag Use of benzoxaborole as fungicides
WO2018060140A1 (en) * 2016-09-27 2018-04-05 Syngenta Participations Ag Microbiocidal benzoxaboroles derivatives

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101505603A (en) * 2005-12-30 2009-08-12 安纳考尔医药公司 Boron-containing small molecules
CN103857289A (en) * 2011-10-07 2014-06-11 先正达参股股份有限公司 Method for protecting useful plants or plant propagation material
US8669207B1 (en) * 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
CN105101791A (en) * 2013-01-30 2015-11-25 美国陶氏益农公司 Use of phenylboronic acid half esters as volatile antimicrobial agents on meat, plants or plant parts
WO2014173880A1 (en) * 2013-04-22 2014-10-30 Syngenta Participations Ag Novel microbiocides
US20170000133A1 (en) * 2013-12-23 2017-01-05 Syngenta Participations Ag Benzoxaborole fungicides
WO2015097276A1 (en) * 2013-12-23 2015-07-02 Syngenta Participations Ag Benzoxaborole fungicides
CN106029673A (en) * 2014-02-17 2016-10-12 先正达参股股份有限公司 Microbiocidally active benzoxaboroles
GB2531098A (en) * 2014-05-28 2016-04-13 Syngenta Participations Ag Novel microbiocides
CN107108661A (en) * 2015-01-13 2017-08-29 先正达参股股份有限公司 Kill the benzoxaborole heterocyclic pentene of microorganism
WO2017029289A1 (en) * 2015-08-17 2017-02-23 Syngenta Participations Ag 1-hydroxy-3h-2,1-benzoxaborole derivatives and their use as microbiocides
WO2017216191A1 (en) * 2016-06-13 2017-12-21 Syngenta Participations Ag Use of benzoxaborole as fungicides
WO2018060140A1 (en) * 2016-09-27 2018-04-05 Syngenta Participations Ag Microbiocidal benzoxaboroles derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
赵立立: "STN检索报告", 《STN检索报告 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11834466B2 (en) 2017-11-30 2023-12-05 5Metis, Inc. Benzoxaborole compounds and formulations thereof
US11560393B2 (en) 2018-08-18 2023-01-24 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
US12098159B2 (en) 2018-08-18 2024-09-24 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
CN116715692A (en) * 2023-06-20 2023-09-08 广西田园生化股份有限公司 Application of oxaborane compound in prevention and treatment of plant diseases

Similar Documents

Publication Publication Date Title
AU2010301675B2 (en) Novel phenol derivative
Lu et al. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2, 6-dichlorobenzyloxy) phenyl thiazole, oxazole and imidazole derivatives. Part 2
CN102869255B (en) The novel inhibitors of GSNO reductase
AU2013366898B2 (en) Halogen-substituted heterocyclic compound
CN111233908A (en) Benzoxaborol-1-ol compound and preparation method and application thereof
CA2971125C (en) Urat1 inhibitor
TW200800896A (en) Organic compounds
JPWO2003000686A1 (en) Isoxazoline derivatives and herbicides
TW200906400A (en) Aryl derivative
CA2914620A1 (en) Heterocyclic derivatives and use thereof
CN103360317B (en) Bicycle substituted pyrazolone azo analog derivative, Preparation Method And The Use
US20120101091A1 (en) Viral polymerase inhibitors
TW209216B (en)
CA2578168A1 (en) 2-phenylpyridine derivative
CN101875639A (en) Substituted pyrimidine ether compounds and their applications
JPWO2006022375A1 (en) 2-Phenylthiophene derivatives
CN110183386B (en) Diclazuril derivative, application thereof and bactericide containing diclazuril derivative
US7273878B2 (en) Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
JP2007308402A (en) Cinnamoyl compounds and uses thereof
JP2001089453A (en) Heteroaryloxy (thio) alkanoic acid amide derivatives and fungicides for agricultural and horticultural use
Mersal et al. Design, synthesis, in vitro determination and molecular docking studies of 4-(1-(tert-butyl)-3-phenyl-1H-pyrazol-4-yl) pyridine derivatives with terminal sulfonamide derivatives in LPS-induced RAW264. 7 macrophage cells
TW200815324A (en) Straight chain amine compound
US11247977B2 (en) Compound and use thereof in synthesis of brivaracetam intermediate and crude drug
NZ529280A (en) Oxazin (Ethi) one compounds as fungicides
CA1336193C (en) Process for preparing haloalkyl thiazoles and haloalkyl thiazoles prepared thereby

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200605